103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
SB3114
 
Introduced 2/2/2024, by Sen. Ann Gillespie
 
SYNOPSIS AS INTRODUCED:

225 ILCS 95/4 from Ch. 111, par. 4604
225 ILCS 95/6 from Ch. 111, par. 4606
225 ILCS 95/7 from Ch. 111, par. 4607
225 ILCS 95/7.5
225 ILCS 95/7.7
225 ILCS 95/7.8 new
225 ILCS 95/7.9 new
225 ILCS 95/17 from Ch. 111, par. 4617
225 ILCS 95/20 from Ch. 111, par. 4620
225 ILCS 95/21 from Ch. 111, par. 4621
720 ILCS 570/102 from Ch. 56 1/2, par. 1102
720 ILCS 570/303.05
 Amends the Physician Assistant Practice Act of 1987. Provides that a physician assistant may prescribe, dispense, order, administer, and procure drugs and medical devices without delegation of authority by a physician. Provides that a physician assistant may practice without a written collaborative agreement. Provides that a physician assistant who files with the Department of Financial and Professional Regulation a notarized attestation of completion of at least 250 hours of continuing education or training and at least 2,000 hours of clinical experience after first attaining national certification shall not require a written collaborative agreement. Makes changes in provisions concerning definitions; physician assistant title; collaboration requirements; written collaborative agreements, prescriptive authority, and physician assistants in hospitals, hospital affiliates, or ambulatory surgical treatment centers; inactive status; limitations; and grounds for disciplinary action. Amends the Illinois Controlled Substances Act to make corresponding changes.


LRB103 39234 SPS 69386 b


 
 
A BILL FOR
 
SB3114LRB103 39234 SPS 69386 b


1 AN ACT concerning regulation.

2 Be it enacted by the People of the State of Illinois, 
3represented in the General Assembly:

4 Section 5. The Physician Assistant Practice Act of 1987 is 
5amended by changing Sections 4, 6, 7, 7.5, 7.7, 17, 20, and 21 
6and by adding Sections 7.8 and 7.9 as follows:

7 (225 ILCS 95/4) (from Ch. 111, par. 4604)
8 (Text of Section before amendment by P.A. 103-65)
9 (Section scheduled to be repealed on January 1, 2028)
10 Sec. 4. Definitions. In this Act: 
11 1. "Department" means the Department of Financial and 
12Professional Regulation.
13 2. "Secretary" means the Secretary of Financial and 
14Professional Regulation.
15 3. "Physician assistant" means any person not holding an 
16active license or permit issued by the Department pursuant to 
17the Medical Practice Act of 1987 who has been certified as a 
18physician assistant by the National Commission on the 
19Certification of Physician Assistants or equivalent successor 
20agency and performs procedures in collaboration with a 
21physician as defined in this Act. A physician assistant may 
22perform such procedures within the specialty of the 
23collaborating physician, except that such physician shall 
 
 
SB3114- 2 -LRB103 39234 SPS 69386 b


1exercise such direction, collaboration, and control over such 
2physician assistants as will assure that patients shall 
3receive quality medical care. Physician assistants shall be 
4capable of performing a variety of tasks within the specialty 
5of medical care in collaboration with a physician. 
6Collaboration with the physician assistant shall not be 
7construed to necessarily require the personal presence of the 
8collaborating physician at all times at the place where 
9services are rendered, as long as there is communication 
10available for consultation by radio, telephone or 
11telecommunications within established guidelines as determined 
12by the physician/physician assistant team. The collaborating 
13physician may delegate tasks and duties to the physician 
14assistant. Delegated tasks or duties shall be consistent with 
15physician assistant education, training, and experience. The 
16delegated tasks or duties shall be specific to the practice 
17setting and shall be implemented and reviewed under a written 
18collaborative agreement established by the physician or 
19physician/physician assistant team. A physician assistant, 
20acting as an agent of the physician, shall be permitted to 
21transmit the collaborating physician's orders as determined by 
22the institution's bylaws by-laws, policies, procedures, or job 
23description within which the physician/physician assistant 
24team practices. Physician assistants shall practice only in 
25accordance with a written collaborative agreement.
26 Any person who holds an active license or permit issued 
 
 
SB3114- 3 -LRB103 39234 SPS 69386 b


1pursuant to the Medical Practice Act of 1987 shall have that 
2license automatically placed into inactive status upon 
3issuance of a physician assistant license. Any person who 
4holds an active license as a physician assistant who is issued 
5a license or permit pursuant to the Medical Practice Act of 
61987 shall have his or her physician assistant license 
7automatically placed into inactive status.
8 3.5. "Physician assistant practice" means the performance 
9of procedures within the specialty of the collaborating 
10physician. Physician assistants shall be capable of performing 
11a variety of tasks within the specialty of medical care of the 
12collaborating physician. Collaboration with the physician 
13assistant shall not be construed to necessarily require the 
14personal presence of the collaborating physician at all times 
15at the place where services are rendered, as long as there is 
16communication available for consultation by radio, telephone, 
17telecommunications, or electronic communications. The 
18collaborating physician may delegate tasks and duties to the 
19physician assistant. Delegated tasks or duties shall be 
20consistent with physician assistant education, training, and 
21experience. The delegated tasks or duties shall be specific to 
22the practice setting and shall be implemented and reviewed 
23under a written collaborative agreement established by the 
24physician or physician/physician assistant team. A physician 
25assistant shall be permitted to transmit the collaborating 
26physician's orders as determined by the institution's bylaws, 
 
 
SB3114- 4 -LRB103 39234 SPS 69386 b


1policies, or procedures or the job description within which 
2the physician/physician assistant team practices. Physician 
3assistants shall practice only in accordance with a written 
4collaborative agreement, except as provided in Section 7.5 of 
5this Act.
6 4. "Board" means the Medical Licensing Board constituted 
7under the Medical Practice Act of 1987.
8 5. (Blank).
9 6. "Physician" means a person licensed to practice 
10medicine in all of its branches under the Medical Practice Act 
11of 1987.
12 7. "Collaborating physician" means the physician who, 
13within his or her specialty and expertise, may delegate a 
14variety of tasks and procedures to the physician assistant. 
15Such tasks and procedures shall be delegated in accordance 
16with a written collaborative agreement.
17 8. (Blank).
18 9. "Address of record" means the designated address 
19recorded by the Department in the applicant's or licensee's 
20application file or license file maintained by the 
21Department's licensure maintenance unit.
22 10. "Hospital affiliate" means a corporation, partnership, 
23joint venture, limited liability company, or similar 
24organization, other than a hospital, that is devoted primarily 
25to the provision, management, or support of health care 
26services and that directly or indirectly controls, is 
 
 
SB3114- 5 -LRB103 39234 SPS 69386 b


1controlled by, or is under common control of the hospital. For 
2the purposes of this definition, "control" means having at 
3least an equal or a majority ownership or membership interest. 
4A hospital affiliate shall be 100% owned or controlled by any 
5combination of hospitals, their parent corporations, or 
6physicians licensed to practice medicine in all its branches 
7in Illinois. "Hospital affiliate" does not include a health 
8maintenance organization regulated under the Health 
9Maintenance Organization Act. 
10 11. "Email address of record" means the designated email 
11address recorded by the Department in the applicant's 
12application file or the licensee's license file, as maintained 
13by the Department's licensure maintenance unit. 
14(Source: P.A. 102-1117, eff. 1-13-23.)

15 (Text of Section after amendment by P.A. 103-65)
16 (Section scheduled to be repealed on January 1, 2028)
17 Sec. 4. Definitions. In this Act: 
18 1. "Department" means the Department of Financial and 
19Professional Regulation.
20 2. "Secretary" means the Secretary of Financial and 
21Professional Regulation.
22 3. "Physician assistant" means any person not holding an 
23active license or permit issued by the Department pursuant to 
24the Medical Practice Act of 1987 who has been certified as a 
25physician assistant by the National Commission on the 
 
 
SB3114- 6 -LRB103 39234 SPS 69386 b


1Certification of Physician Assistants or equivalent successor 
2agency. and performs procedures in collaboration with a 
3physician as defined in this Act. A physician assistant may 
4perform such procedures within the specialty of the 
5collaborating physician, except that such physician shall 
6exercise such direction, collaboration, and control over such 
7physician assistants as will assure that patients shall 
8receive quality medical care. Physician assistants shall be 
9capable of performing a variety of tasks within the specialty 
10of medical care in collaboration with a physician. 
11Collaboration with the physician assistant shall not be 
12construed to necessarily require the personal presence of the 
13collaborating physician at all times at the place where 
14services are rendered, as long as there is communication 
15available for consultation by radio, telephone or 
16telecommunications within established guidelines as determined 
17by the physician/physician assistant team. The collaborating 
18physician may delegate tasks and duties to the physician 
19assistant. Delegated tasks or duties shall be consistent with 
20physician assistant education, training, and experience. The 
21delegated tasks or duties shall be specific to the practice 
22setting and shall be implemented and reviewed under a written 
23collaborative agreement established by the physician or 
24physician/physician assistant team. A physician assistant, 
25acting as an agent of the physician, shall be permitted to 
26transmit the collaborating physician's orders as determined by 
 
 
SB3114- 7 -LRB103 39234 SPS 69386 b


1the institution's by-laws, policies, procedures, or job 
2description within which the physician/physician assistant 
3team practices. Physician assistants shall practice only in 
4accordance with a written collaborative agreement.
5 Any person who holds an active license or permit issued 
6pursuant to the Medical Practice Act of 1987 shall have that 
7license automatically placed into inactive status upon 
8issuance of a physician assistant license. Any person who 
9holds an active license as a physician assistant who is issued 
10a license or permit pursuant to the Medical Practice Act of 
111987 shall have his or her physician assistant license 
12automatically placed into inactive status. 
13 3.5. "Physician assistant practice" means the performance 
14of any legal medical service for which the physician assistant 
15has been prepared by the physician assistant's education, 
16training, and experience and is competent to perform as 
17determined by the practice through employment agreement or 
18credentialing and privileging system of the licensed facility. 
19Medical and surgical services provided by physician assistants 
20include, but are not limited to:
21  (A) obtaining and performing comprehensive health 
22 histories and physical examinations;
23  (B) evaluating, diagnosing, managing, and providing 
24 medical treatment;
25  (C) ordering, performing, and interpreting diagnostic 
26 studies and therapeutic procedures;
 
 
SB3114- 8 -LRB103 39234 SPS 69386 b


1  (D) educating patients on health promotion and disease 
2 prevention;
3  (E) providing consultation upon request;
4  (F) writing medical orders;
5  (G) prescribing, dispensing, ordering, administering, 
6 and procuring drugs and medical devices; and
7  (H) assisting in surgery. procedures within the 
8 specialty of the collaborating physician. Physician 
9 assistants shall be capable of performing a variety of 
10 tasks within the specialty of medical care of the 
11 collaborating physician. Collaboration with the physician 
12 assistant shall not be construed to necessarily require 
13 the personal presence of the collaborating physician at 
14 all times at the place where services are rendered, as 
15 long as there is communication available for consultation 
16 by radio, telephone, telecommunications, or electronic 
17 communications. The collaborating physician may delegate 
18 tasks and duties to the physician assistant. Delegated 
19 tasks or duties shall be consistent with physician 
20 assistant education, training, and experience. The 
21 delegated tasks or duties shall be specific to the 
22 practice setting and shall be implemented and reviewed 
23 under a written collaborative agreement established by the 
24 physician or physician/physician assistant team. A 
25 physician assistant shall be permitted to transmit the 
26 collaborating physician's orders as determined by the 
 
 
SB3114- 9 -LRB103 39234 SPS 69386 b


1 institution's bylaws, policies, or procedures or the job 
2 description within which the physician/physician assistant 
3 team practices. Physician assistants shall practice only 
4 in accordance with a written collaborative agreement, 
5 except as provided in Section 7.5 of this Act.
6 4. "Board" means the Illinois State Medical Board Medical 
7Licensing Board constituted under the Medical Practice Act of 
81987.
9 5. (Blank).
10 6. "Physician" means a person licensed to practice 
11medicine in all of its branches under the Medical Practice Act 
12of 1987.
13 7. "Collaborating physician" means the physician who, 
14within his or her specialty and expertise, may delegate a 
15variety of tasks and procedures to the physician assistant. 
16Such tasks and procedures shall be delegated in accordance 
17with a written collaborative agreement when the agreement is 
18required under this Act.
19 8. (Blank).
20 9. "Address of record" means the designated address 
21recorded by the Department in the applicant's or licensee's 
22application file or license file maintained by the 
23Department's licensure maintenance unit.
24 10. "Hospital affiliate" means a corporation, partnership, 
25joint venture, limited liability company, or similar 
26organization, other than a hospital, that is devoted primarily 
 
 
SB3114- 10 -LRB103 39234 SPS 69386 b


1to the provision, management, or support of health care 
2services and that directly or indirectly controls, is 
3controlled by, or is under common control of the hospital. For 
4the purposes of this definition, "control" means having at 
5least an equal or a majority ownership or membership interest. 
6A hospital affiliate shall be 100% owned or controlled by any 
7combination of hospitals, their parent corporations, or 
8physicians licensed to practice medicine in all its branches 
9in Illinois. "Hospital affiliate" does not include a health 
10maintenance organization regulated under the Health 
11Maintenance Organization Act.
12 11. "Email address of record" means the designated email 
13address recorded by the Department in the applicant's 
14application file or the licensee's license file, as maintained 
15by the Department's licensure maintenance unit.
16 12. "Federally qualified health center" means a health 
17center funded under Section 330 of the federal Public Health 
18Service Act.
19(Source: P.A. 102-1117, eff. 1-13-23; 103-65, eff. 1-1-24.)

20 (225 ILCS 95/6) (from Ch. 111, par. 4606)
21 (Section scheduled to be repealed on January 1, 2028)
22 Sec. 6. Physician assistant title. 
23 (a) No physician assistant shall use the title of doctor, 
24physician, or associate with his or her name or any other term 
25that would indicate to other persons that he or she is 
 
 
SB3114- 11 -LRB103 39234 SPS 69386 b


1qualified to engage in the general practice of medicine.
2 (b) A physician assistant shall verbally identify himself 
3or herself as a physician assistant, including, when 
4applicable, specialty certification, to each patient.
5 (c) Nothing in this Act shall be construed to relieve a 
6physician assistant of the professional or legal 
7responsibility for the care and treatment of persons attended 
8by him or her.
9 (d) (Blank). The collaborating physician shall file with 
10the Department notice of employment, discharge, or 
11collaboration with a physician assistant within 60 days of 
12employment, discharge, or assumption of collaboration with a 
13physician assistant. Nothing in this Section shall prevent a 
14physician assistant from beginning his or her employment 
15before the notice of employment or collaboration has been 
16filed. 
17(Source: P.A. 102-735, eff. 1-1-23.)

18 (225 ILCS 95/7) (from Ch. 111, par. 4607)
19 (Text of Section before amendment by P.A. 103-65)
20 (Section scheduled to be repealed on January 1, 2028)
21 Sec. 7. Collaboration requirements. 
22 (a) A collaborating physician shall determine the number 
23of physician assistants to collaborate with, provided the 
24physician is able to provide adequate collaboration as 
25outlined in the written collaborative agreement required under 
 
 
SB3114- 12 -LRB103 39234 SPS 69386 b


1Section 7.5 of this Act and consideration is given to the 
2nature of the physician's practice, complexity of the patient 
3population, and the experience of each physician assistant. A 
4collaborating physician may collaborate with a maximum of 7 
5full-time equivalent physician assistants as described in 
6Section 54.5 of the Medical Practice Act of 1987. As used in 
7this Section, "full-time equivalent" means the equivalent of 
840 hours per week per individual. Physicians and physician 
9assistants who work in a hospital, hospital affiliate, or 
10ambulatory surgical treatment center as defined by Section 7.7 
11of this Act are exempt from the collaborative ratio 
12restriction requirements of this Section. A physician 
13assistant shall be able to hold more than one professional 
14position. A collaborating physician shall file a notice of 
15collaboration of each physician assistant according to the 
16rules of the Department.
17 Physician assistants shall collaborate only with 
18physicians as defined in this Act who are engaged in clinical 
19practice, or in clinical practice in public health or other 
20community health facilities.
21 Nothing in this Act shall be construed to limit the 
22delegation of tasks or duties by a physician to a nurse or 
23other appropriately trained personnel.
24 Nothing in this Act shall be construed to prohibit the 
25employment of physician assistants by a hospital, nursing home 
26or other health care facility where such physician assistants 
 
 
SB3114- 13 -LRB103 39234 SPS 69386 b


1function with under a collaborating physician.
2 A physician assistant may be employed by a practice group 
3or other entity employing multiple physicians at one or more 
4locations. In that case, one of the physicians practicing at a 
5location shall be designated the collaborating physician. The 
6other physicians with that practice group or other entity who 
7practice in the same general type of practice or specialty as 
8the collaborating physician may collaborate with the physician 
9assistant with respect to their patients.
10 (b) A physician assistant licensed in this State, or 
11licensed or authorized to practice in any other U.S. 
12jurisdiction or credentialed by his or her federal employer as 
13a physician assistant, who is responding to a need for medical 
14care created by an emergency or by a state or local disaster 
15may render such care that the physician assistant is able to 
16provide without collaboration as it is defined in this Section 
17or with such collaboration as is available.
18 Any physician who collaborates with a physician assistant 
19providing medical care in response to such an emergency or 
20state or local disaster shall not be required to meet the 
21requirements set forth in this Section for a collaborating 
22physician.
23(Source: P.A. 100-453, eff. 8-25-17; 100-605, eff. 1-1-19.)

24 (Text of Section after amendment by P.A. 103-65)
25 (Section scheduled to be repealed on January 1, 2028)
 
 
SB3114- 14 -LRB103 39234 SPS 69386 b


1 Sec. 7. Collaboration requirements. 
2 (a) A written collaborative agreement is required for all 
3physician assistants engaged in clinical practice prior to 
4satisfying the requirements of Section 7.9, except for 
5physician assistants who practice in a hospital, hospital 
6affiliate, federally qualified health center, or ambulatory 
7surgical treatment center as provided in Section 7.7. 
8 (b) (a) A collaborating physician shall determine the 
9number of physician assistants to collaborate with, provided 
10the physician is able to provide adequate collaboration as 
11outlined in the written collaborative agreement required under 
12Section 7.5 of this Act and consideration is given to the 
13nature of the physician's practice, complexity of the patient 
14population, and the experience of each physician assistant. A 
15collaborating physician may collaborate with a maximum of 7 
16full-time equivalent physician assistants as described in 
17Section 54.5 of the Medical Practice Act of 1987. As used in 
18this Section, "full-time equivalent" means the equivalent of 
1940 hours per week per individual. Physicians and physician 
20assistants who work in a hospital, hospital affiliate, 
21federally qualified health center, or ambulatory surgical 
22treatment center as defined by Section 7.7 of this Act are 
23exempt from the collaborative ratio restriction requirements 
24of this Section. A physician assistant shall be able to hold 
25more than one professional position. A collaborating physician 
26shall file a notice of collaboration of each physician 
 
 
SB3114- 15 -LRB103 39234 SPS 69386 b


1assistant according to the rules of the Department.
2 (c) Physician assistants shall collaborate only with 
3physicians as defined in this Act who are engaged in clinical 
4practice, or in clinical practice in public health or other 
5community health facilities.
6 (d) Nothing in this Act shall be construed to limit the 
7delegation of tasks or duties by a physician to a nurse or 
8other appropriately trained personnel.
9 (e) Nothing in this Act shall be construed to prohibit the 
10employment of physician assistants by a hospital, nursing home 
11or other health care facility where such physician assistants 
12function with under a collaborating physician.
13 (f) A physician assistant may be employed by a practice 
14group or other entity employing multiple physicians at one or 
15more locations. In that case, one of the physicians practicing 
16at a location shall be designated the collaborating physician. 
17The other physicians with that practice group or other entity 
18who practice in the same general type of practice or specialty 
19as the collaborating physician may collaborate with the 
20physician assistant with respect to their patients.
21 (g) (b) A physician assistant licensed in this State, or 
22licensed or authorized to practice in any other U.S. 
23jurisdiction or credentialed by his or her federal employer as 
24a physician assistant, who is responding to a need for medical 
25care created by an emergency or by a state or local disaster 
26may render such care that the physician assistant is able to 
 
 
SB3114- 16 -LRB103 39234 SPS 69386 b


1provide without collaboration as it is defined in this Section 
2or with such collaboration as is available.
3 (h) Any physician who collaborates with a physician 
4assistant providing medical care in response to such an 
5emergency or state or local disaster shall not be required to 
6meet the requirements set forth in this Section for a 
7collaborating physician.
8(Source: P.A. 103-65, eff. 1-1-24.)

9 (225 ILCS 95/7.5)
10 (Text of Section before amendment by P.A. 103-65)
11 (Section scheduled to be repealed on January 1, 2028)
12 Sec. 7.5. Written collaborative agreements; prescriptive 
13authority. 
14 (a) A written collaborative agreement is required for all 
15physician assistants to practice in the State, except as 
16provided in Section 7.7 of this Act.
17  (1) A written collaborative agreement shall describe 
18 the working relationship of the physician assistant with 
19 the collaborating physician and shall describe the 
20 categories of care, treatment, or procedures to be 
21 provided by the physician assistant. The written 
22 collaborative agreement shall promote the exercise of 
23 professional judgment by the physician assistant 
24 commensurate with his or her education and experience. The 
25 services to be provided by the physician assistant shall 
 
 
SB3114- 17 -LRB103 39234 SPS 69386 b


1 be services that the collaborating physician is authorized 
2 to and generally provides to his or her patients in the 
3 normal course of his or her clinical medical practice. The 
4 written collaborative agreement need not describe the 
5 exact steps that a physician assistant must take with 
6 respect to each specific condition, disease, or symptom 
7 but must specify which authorized procedures require the 
8 presence of the collaborating physician as the procedures 
9 are being performed. The relationship under a written 
10 collaborative agreement shall not be construed to require 
11 the personal presence of a physician at the place where 
12 services are rendered. Methods of communication shall be 
13 available for consultation with the collaborating 
14 physician in person or by telecommunications or electronic 
15 communications as set forth in the written collaborative 
16 agreement. For the purposes of this Act, "generally 
17 provides to his or her patients in the normal course of his 
18 or her clinical medical practice" means services, not 
19 specific tasks or duties, the collaborating physician 
20 routinely provides individually or through delegation to 
21 other persons so that the physician has the experience and 
22 ability to collaborate and provide consultation.
23  (2) The written collaborative agreement shall be 
24 adequate if a physician does each of the following:
25   (A) Participates in the joint formulation and 
26 joint approval of orders or guidelines with the 
 
 
SB3114- 18 -LRB103 39234 SPS 69386 b


1 physician assistant and he or she periodically reviews 
2 such orders and the services provided patients under 
3 such orders in accordance with accepted standards of 
4 medical practice and physician assistant practice.
5   (B) Provides consultation at least once a month.
6  (3) A copy of the signed, written collaborative 
7 agreement must be available to the Department upon request 
8 from both the physician assistant and the collaborating 
9 physician.
10  (4) A physician assistant shall inform each 
11 collaborating physician of all written collaborative 
12 agreements he or she has signed and provide a copy of these 
13 to any collaborating physician upon request.
14 (b) A collaborating physician may, but is not required to, 
15delegate prescriptive authority to a physician assistant as 
16part of a written collaborative agreement. This authority may, 
17but is not required to, include prescription of, selection of, 
18orders for, administration of, storage of, acceptance of 
19samples of, and dispensing medical devices, over-the-counter 
20over the counter medications, legend drugs, medical gases, and 
21controlled substances categorized as Schedule II through V 
22controlled substances, as defined in Article II of the 
23Illinois Controlled Substances Act, and other preparations, 
24including, but not limited to, botanical and herbal remedies. 
25The collaborating physician must have a valid, current 
26Illinois controlled substance license and federal registration 
 
 
SB3114- 19 -LRB103 39234 SPS 69386 b


1with the Drug Enforcement Administration to delegate the 
2authority to prescribe controlled substances.
3  (1) To prescribe Schedule II, III, IV, or V controlled 
4 substances under this Section, a physician assistant must 
5 obtain a mid-level practitioner controlled substances 
6 license. Medication orders issued by a physician assistant 
7 shall be reviewed periodically by the collaborating 
8 physician.
9  (2) The collaborating physician shall file with the 
10 Department notice of delegation of prescriptive authority 
11 to a physician assistant and termination of delegation, 
12 specifying the authority delegated or terminated. Upon 
13 receipt of this notice delegating authority to prescribe 
14 controlled substances, the physician assistant shall be 
15 eligible to register for a mid-level practitioner 
16 controlled substances license under Section 303.05 of the 
17 Illinois Controlled Substances Act. Nothing in this Act 
18 shall be construed to limit the delegation of tasks or 
19 duties by the collaborating physician to a nurse or other 
20 appropriately trained persons in accordance with Section 
21 54.2 of the Medical Practice Act of 1987.
22  (3) In addition to the requirements of this subsection 
23 (b), a collaborating physician may, but is not required 
24 to, delegate authority to a physician assistant to 
25 prescribe Schedule II controlled substances, if all of the 
26 following conditions apply:
 
 
SB3114- 20 -LRB103 39234 SPS 69386 b


1   (A) Specific Schedule II controlled substances by 
2 oral dosage or topical or transdermal application may 
3 be delegated, provided that the delegated Schedule II 
4 controlled substances are routinely prescribed by the 
5 collaborating physician. This delegation must identify 
6 the specific Schedule II controlled substances by 
7 either brand name or generic name. Schedule II 
8 controlled substances to be delivered by injection or 
9 other route of administration may not be delegated.
10   (B) (Blank).
11   (C) Any prescription must be limited to no more 
12 than a 30-day supply, with any continuation authorized 
13 only after prior approval of the collaborating 
14 physician.
15   (D) The physician assistant must discuss the 
16 condition of any patients for whom a controlled 
17 substance is prescribed monthly with the collaborating 
18 physician.
19   (E) The physician assistant meets the education 
20 requirements of Section 303.05 of the Illinois 
21 Controlled Substances Act.
22 (c) Nothing in this Act shall be construed to limit the 
23delegation of tasks or duties by a physician to a licensed 
24practical nurse, a registered professional nurse, or other 
25persons. Nothing in this Act shall be construed to limit the 
26method of delegation that may be authorized by any means, 
 
 
SB3114- 21 -LRB103 39234 SPS 69386 b


1including, but not limited to, oral, written, electronic, 
2standing orders, protocols, guidelines, or verbal orders. 
3Nothing in this Act shall be construed to authorize a 
4physician assistant to provide health care services required 
5by law or rule to be performed by a physician. Nothing in this 
6Act shall be construed to authorize the delegation or 
7performance of operative surgery. Nothing in this Section 
8shall be construed to preclude a physician assistant from 
9assisting in surgery.
10 (c-5) Nothing in this Section shall be construed to apply 
11to any medication authority, including Schedule II controlled 
12substances of a licensed physician assistant for care provided 
13in a hospital, hospital affiliate, or ambulatory surgical 
14treatment center pursuant to Section 7.7 of this Act.
15 (d) (Blank). 
16 (e) Nothing in this Section shall be construed to prohibit 
17generic substitution. 
18(Source: P.A. 101-13, eff. 6-12-19; 102-558, eff. 8-20-21; 
19revised 9-21-23.)

20 (Text of Section after amendment by P.A. 103-65)
21 (Section scheduled to be repealed on January 1, 2028)
22 Sec. 7.5. Written collaborative agreements; prescriptive 
23authority. 
24 (a) A written collaborative agreement is required for all 
25physician assistants to practice in the State, except as 
 
 
SB3114- 22 -LRB103 39234 SPS 69386 b


1provided in Sections Section 7.7 and 7.9 of this Act. When a 
2written collaborative agreement is required under this Act, 
3the following shall apply:
4  (1) A written collaborative agreement shall describe 
5 the working relationship of the physician assistant with 
6 the collaborating physician and shall describe the 
7 categories of care, treatment, or procedures to be 
8 provided by the physician assistant. The written 
9 collaborative agreement shall promote the exercise of 
10 professional judgment by the physician assistant 
11 commensurate with his or her education and experience. The 
12 services to be provided by the physician assistant shall 
13 be services that the collaborating physician is authorized 
14 to and generally provides to his or her patients in the 
15 normal course of his or her clinical medical practice. The 
16 written collaborative agreement need not describe the 
17 exact steps that a physician assistant must take with 
18 respect to each specific condition, disease, or symptom 
19 but must specify which authorized procedures require the 
20 presence of the collaborating physician as the procedures 
21 are being performed. The relationship under a written 
22 collaborative agreement shall not be construed to require 
23 the personal presence of a physician at the place where 
24 services are rendered. Methods of communication shall be 
25 available for consultation with the collaborating 
26 physician in person or by telecommunications or electronic 
 
 
SB3114- 23 -LRB103 39234 SPS 69386 b


1 communications as set forth in the written collaborative 
2 agreement. For the purposes of this Act, "generally 
3 provides to his or her patients in the normal course of his 
4 or her clinical medical practice" means services, not 
5 specific tasks or duties, the collaborating physician 
6 routinely provides individually or through delegation to 
7 other persons so that the physician has the experience and 
8 ability to collaborate and provide consultation.
9  (2) (Blank). The written collaborative agreement shall 
10 be adequate if a physician does each of the following:
11   (A) Participates in the joint formulation and 
12 joint approval of orders or guidelines with the 
13 physician assistant and he or she periodically reviews 
14 such orders and the services provided patients under 
15 such orders in accordance with accepted standards of 
16 medical practice and physician assistant practice.
17   (B) Provides consultation at least once a month. 
18  (3) A copy of the signed, written collaborative 
19 agreement must be available to the Department upon request 
20 from both the physician assistant and the collaborating 
21 physician.
22  (4) A physician assistant shall inform each 
23 collaborating physician of all written collaborative 
24 agreements he or she has signed and provide a copy of these 
25 to any collaborating physician upon request.
26 (b) To prescribe Schedule II, III, IV, or V controlled 
 
 
SB3114- 24 -LRB103 39234 SPS 69386 b


1substances under this Section, a physician assistant must 
2obtain a mid-level practitioner controlled substances license. 
3A collaborating physician may, but is not required to, 
4delegate prescriptive authority to a physician assistant as 
5part of a written collaborative agreement. This authority may, 
6but is not required to, include prescription of, selection of, 
7orders for, administration of, storage of, acceptance of 
8samples of, and dispensing medical devices, over the counter 
9medications, legend drugs, medical gases, and controlled 
10substances categorized as Schedule II through V controlled 
11substances, as defined in Article II of the Illinois 
12Controlled Substances Act, and other preparations, including, 
13but not limited to, botanical and herbal remedies. The 
14collaborating physician must have a valid, current Illinois 
15controlled substance license and federal registration with the 
16Drug Enforcement Administration to delegate the authority to 
17prescribe controlled substances.
18  (1) To prescribe Schedule II, III, IV, or V controlled 
19 substances under this Section, a physician assistant must 
20 obtain a mid-level practitioner controlled substances 
21 license. Medication orders issued by a physician assistant 
22 shall be reviewed periodically by the collaborating 
23 physician.
24  (2) The collaborating physician shall file with the 
25 Department notice of delegation of prescriptive authority 
26 to a physician assistant and termination of delegation, 
 
 
SB3114- 25 -LRB103 39234 SPS 69386 b


1 specifying the authority delegated or terminated. Upon 
2 receipt of this notice delegating authority to prescribe 
3 controlled substances, the physician assistant shall be 
4 eligible to register for a mid-level practitioner 
5 controlled substances license under Section 303.05 of the 
6 Illinois Controlled Substances Act. Nothing in this Act 
7 shall be construed to limit the delegation of tasks or 
8 duties by the collaborating physician to a nurse or other 
9 appropriately trained persons in accordance with Section 
10 54.2 of the Medical Practice Act of 1987.
11  (3) In addition to the requirements of this subsection 
12 (b), a collaborating physician may, but is not required 
13 to, delegate authority to a physician assistant to 
14 prescribe Schedule II controlled substances, if all of the 
15 following conditions apply:
16   (A) Specific Schedule II controlled substances by 
17 oral dosage or topical or transdermal application may 
18 be delegated, provided that the delegated Schedule II 
19 controlled substances are routinely prescribed by the 
20 collaborating physician. This delegation must identify 
21 the specific Schedule II controlled substances by 
22 either brand name or generic name. Schedule II 
23 controlled substances to be delivered by injection or 
24 other route of administration may not be delegated.
25   (B) (Blank).
26   (C) Any prescription must be limited to no more 
 
 
SB3114- 26 -LRB103 39234 SPS 69386 b


1 than a 30-day supply, with any continuation authorized 
2 only after prior approval of the collaborating 
3 physician.
4   (D) The physician assistant must discuss the 
5 condition of any patients for whom a controlled 
6 substance is prescribed monthly with the collaborating 
7 physician.
8   (E) The physician assistant meets the education 
9 requirements of Section 303.05 of the Illinois 
10 Controlled Substances Act. 
11 (c) Nothing in this Act shall be construed to limit the 
12delegation of tasks or duties by a physician to a licensed 
13practical nurse, a registered professional nurse, or other 
14persons. Nothing in this Act shall be construed to limit the 
15method of delegation that may be authorized by any means, 
16including, but not limited to, oral, written, electronic, 
17standing orders, protocols, guidelines, or verbal orders. 
18Nothing in this Act shall be construed to authorize a 
19physician assistant to provide health care services required 
20by law or rule to be performed by a physician. Nothing in this 
21Act shall be construed to authorize the delegation or 
22performance of operative surgery. Nothing in this Section 
23shall be construed to preclude a physician assistant from 
24assisting in surgery.
25 (c-5) Nothing in this Section shall be construed to apply 
26to any medication authority, including Schedule II controlled 
 
 
SB3114- 27 -LRB103 39234 SPS 69386 b


1substances of a licensed physician assistant for care provided 
2in a hospital, hospital affiliate, federally qualified health 
3center, or ambulatory surgical treatment center pursuant to 
4Section 7.7 of this Act, or to a physician assistant 
5satisfying the requirements of Section 7.9.
6 (d) (Blank).
7 (e) Nothing in this Section shall be construed to prohibit 
8generic substitution.
9 (f) Delegation of prescriptive authority by a physician is 
10not required under this Section.
11(Source: P.A. 102-558, eff. 8-20-21; 103-65, eff. 1-1-24; 
12revised 9-21-23.)

13 (225 ILCS 95/7.7)
14 (Text of Section before amendment by P.A. 103-65)
15 (Section scheduled to be repealed on January 1, 2028)
16 Sec. 7.7. Physician assistants in hospitals, hospital 
17affiliates, or ambulatory surgical treatment centers.
18 (a) A physician assistant may provide services in a 
19hospital as defined in the Hospital Licensing Act, a hospital 
20affiliate as defined in the University of Illinois Hospital 
21Act, or a licensed ambulatory surgical treatment center as 
22defined in the Ambulatory Surgical Treatment Center Act 
23without a written collaborative agreement pursuant to Section 
247.5 of this Act. A physician assistant must possess clinical 
25privileges recommended by the hospital medical staff and 
 
 
SB3114- 28 -LRB103 39234 SPS 69386 b


1granted by the hospital or the consulting medical staff 
2committee and ambulatory surgical treatment center in order to 
3provide services. The medical staff or consulting medical 
4staff committee shall periodically review the services of 
5physician assistants granted clinical privileges, including 
6any care provided in a hospital affiliate. Authority may also 
7be granted when recommended by the hospital medical staff and 
8granted by the hospital or recommended by the consulting 
9medical staff committee and ambulatory surgical treatment 
10center to individual physician assistants to select, order, 
11and administer medications, including controlled substances, 
12to provide delineated care. In a hospital, hospital affiliate, 
13or ambulatory surgical treatment center, the attending 
14physician shall determine a physician assistant's role in 
15providing care for his or her patients, except as otherwise 
16provided in the medical staff bylaws or consulting committee 
17policies.
18 (a-5) Physician assistants practicing in a hospital 
19affiliate may be, but are not required to be, granted 
20authority to prescribe Schedule II through V controlled 
21substances when such authority is recommended by the 
22appropriate physician committee of the hospital affiliate and 
23granted by the hospital affiliate. This authority may, but is 
24not required to, include prescription of, selection of, orders 
25for, administration of, storage of, acceptance of samples of, 
26and dispensing over-the-counter medications, legend drugs, 
 
 
SB3114- 29 -LRB103 39234 SPS 69386 b


1medical gases, and controlled substances categorized as 
2Schedule II through V controlled substances, as defined in 
3Article II of the Illinois Controlled Substances Act, and 
4other preparations, including, but not limited to, botanical 
5and herbal remedies.
6 To prescribe controlled substances under this subsection 
7(a-5), a physician assistant must obtain a mid-level 
8practitioner controlled substance license. Medication orders 
9shall be reviewed periodically by the appropriate hospital 
10affiliate physicians committee or its physician designee.
11 The hospital affiliate shall file with the Department 
12notice of a grant of prescriptive authority consistent with 
13this subsection (a-5) and termination of such a grant of 
14authority in accordance with rules of the Department. Upon 
15receipt of this notice of grant of authority to prescribe any 
16Schedule II through V controlled substances, the licensed 
17physician assistant may register for a mid-level practitioner 
18controlled substance license under Section 303.05 of the 
19Illinois Controlled Substances Act.
20 In addition, a hospital affiliate may, but is not required 
21to, grant authority to a physician assistant to prescribe any 
22Schedule II controlled substances if all of the following 
23conditions apply:
24  (1) specific Schedule II controlled substances by oral 
25 dosage or topical or transdermal application may be 
26 designated, provided that the designated Schedule II 
 
 
SB3114- 30 -LRB103 39234 SPS 69386 b


1 controlled substances are routinely prescribed by 
2 physician assistants in their area of certification; this 
3 grant of authority must identify the specific Schedule II 
4 controlled substances by either brand name or generic 
5 name; authority to prescribe or dispense Schedule II 
6 controlled substances to be delivered by injection or 
7 other route of administration may not be granted;
8  (2) any grant of authority must be controlled 
9 substances limited to the practice of the physician 
10 assistant;
11  (3) any prescription must be limited to no more than a 
12 30-day supply;
13  (4) the physician assistant must discuss the condition 
14 of any patients for whom a controlled substance is 
15 prescribed monthly with the appropriate physician 
16 committee of the hospital affiliate or its physician 
17 designee; and
18  (5) the physician assistant must meet the education 
19 requirements of Section 303.05 of the Illinois Controlled 
20 Substances Act.
21 (b) A physician assistant granted authority to order 
22medications including controlled substances may complete 
23discharge prescriptions provided the prescription is in the 
24name of the physician assistant and the attending or 
25discharging physician.
26 (c) Physician assistants practicing in a hospital, 
 
 
SB3114- 31 -LRB103 39234 SPS 69386 b


1hospital affiliate, or an ambulatory surgical treatment center 
2are not required to obtain a mid-level controlled substance 
3license to order controlled substances under Section 303.05 of 
4the Illinois Controlled Substances Act.
5(Source: P.A. 100-453, eff. 8-25-17.)

6 (Text of Section after amendment by P.A. 103-65)
7 (Section scheduled to be repealed on January 1, 2028)
8 Sec. 7.7. Physician assistants in hospitals, hospital 
9affiliates, federally qualified health centers, or ambulatory 
10surgical treatment centers.
11 (a) A physician assistant may provide services in a 
12hospital as defined in the Hospital Licensing Act, a hospital 
13affiliate as defined in the University of Illinois Hospital 
14Act, a federally qualified health center, or a licensed 
15ambulatory surgical treatment center as defined in the 
16Ambulatory Surgical Treatment Center Act without a written 
17collaborative agreement pursuant to Section 7.5 of this Act 
18only in accordance with this Section. A physician assistant 
19must possess clinical privileges recommended by (i) the 
20hospital medical staff and granted by the hospital, (ii) the 
21physician committee and federally qualified health center, or 
22(iii) the consulting medical staff committee and ambulatory 
23surgical treatment center in order to provide services. The 
24medical staff, physician committee, or consulting medical 
25staff committee shall periodically review the services of 
 
 
SB3114- 32 -LRB103 39234 SPS 69386 b


1physician assistants granted clinical privileges, including 
2any care provided in a hospital affiliate or federally 
3qualified health center. A physician assistant practicing 
4under this Section may prescribe, select, order, and 
5administer medications, including controlled substances. 
6Authority may also be granted when recommended by the hospital 
7medical staff and granted by the hospital, recommended by the 
8physician committee and granted by the federally qualified 
9health center, or recommended by the consulting medical staff 
10committee and ambulatory surgical treatment center to 
11individual physician assistants to select, order, and 
12administer medications, including controlled substances, to 
13provide delineated care. In a hospital, hospital affiliate, 
14federally qualified health center, or ambulatory surgical 
15treatment center, the attending physician shall determine a 
16physician assistant's role in providing care for his or her 
17patients, except as otherwise provided in the medical staff 
18bylaws or consulting committee policies.
19 (a-5) Physician assistants practicing in a hospital 
20affiliate or a federally qualified health center may be, but 
21are not required to be, granted authority to prescribe 
22Schedule II through V controlled substances when such 
23authority is recommended by the appropriate physician 
24committee of the hospital affiliate and granted by the 
25hospital affiliate or recommended by the physician committee 
26of the federally qualified health center and granted by the 
 
 
SB3114- 33 -LRB103 39234 SPS 69386 b


1federally qualified health center. This authority may, but is 
2not required to, include prescription of, selection of, orders 
3for, administration of, storage of, acceptance of samples of, 
4and dispensing over-the-counter medications, legend drugs, 
5medical gases, and controlled substances categorized as 
6Schedule II through V controlled substances, as defined in 
7Article II of the Illinois Controlled Substances Act, and 
8other preparations, including, but not limited to, botanical 
9and herbal remedies.
10 To prescribe controlled substances under this subsection 
11(a-5), a physician assistant must obtain a mid-level 
12practitioner controlled substance license. Medication orders 
13shall be reviewed periodically by the appropriate hospital 
14affiliate physicians committee or its physician designee or by 
15the physician committee of a federally qualified health 
16center.
17 The hospital affiliate or federally qualified health 
18center shall file with the Department notice of a grant of 
19prescriptive authority consistent with this subsection (a-5) 
20and termination of such a grant of authority in accordance 
21with rules of the Department. Upon receipt of this notice of 
22grant of authority to prescribe any Schedule II through V 
23controlled substances, the licensed physician assistant may 
24register for a mid-level practitioner controlled substance 
25license under Section 303.05 of the Illinois Controlled 
26Substances Act.
 
 
SB3114- 34 -LRB103 39234 SPS 69386 b


1 In addition, a hospital affiliate or a federally qualified 
2health center may, but is not required to, grant authority to a 
3physician assistant to prescribe any Schedule II controlled 
4substances if all of the following conditions apply:
5  (1) specific Schedule II controlled substances by oral 
6 dosage or topical or transdermal application may be 
7 designated, provided that the designated Schedule II 
8 controlled substances are routinely prescribed by 
9 physician assistants in their area of certification; this 
10 grant of authority must identify the specific Schedule II 
11 controlled substances by either brand name or generic 
12 name; authority to prescribe or dispense Schedule II 
13 controlled substances to be delivered by injection or 
14 other route of administration may not be granted;
15  (2) any grant of authority must be controlled 
16 substances limited to the practice of the physician 
17 assistant;
18  (3) any prescription must be limited to no more than a 
19 30-day supply;
20  (4) the physician assistant must discuss the condition 
21 of any patients for whom a controlled substance is 
22 prescribed monthly with the appropriate physician 
23 committee of the hospital affiliate or its physician 
24 designee, or the physician committee of a federally 
25 qualified health center; and
26  (5) the physician assistant must meet the education 
 
 
SB3114- 35 -LRB103 39234 SPS 69386 b


1 requirements of Section 303.05 of the Illinois Controlled 
2 Substances Act. 
3 (b) A physician assistant granted authority to order 
4medications including controlled substances may complete 
5discharge prescriptions provided the prescription is in the 
6name of the physician assistant and the attending or 
7discharging physician.
8 (c) Physician assistants practicing in a hospital, 
9hospital affiliate, federally qualified health center, or an 
10ambulatory surgical treatment center are not required to 
11obtain a mid-level controlled substance license to order 
12controlled substances under Section 303.05 of the Illinois 
13Controlled Substances Act.
14 (d) Delegation of prescriptive authority by a physician is 
15not required under this Section. 
16(Source: P.A. 103-65, eff. 1-1-24.)

17 (225 ILCS 95/7.8 new)
18 Sec. 7.8. Prescriptive authority. A physician assistant 
19may prescribe, dispense, order, administer, and procure drugs 
20and medical devices without delegation of authority by a 
21physician. The prescriptive authority may include prescribing 
22Schedule II, III, IV, and V controlled substances. To 
23prescribe Schedule II, III, IV, or V controlled substances 
24under this Act, a physician assistant must obtain a mid-level 
25practitioner controlled substances license. When a written 
 
 
SB3114- 36 -LRB103 39234 SPS 69386 b


1collaborative agreement is required under this Act, delegation 
2of prescriptive authority by a physician is not required.

3 (225 ILCS 95/7.9 new)
4 Sec. 7.9. Optimal practice.
5 (a) A physician assistant may practice without a written 
6collaborative agreement as described in this Section.
7 (b) A physician assistant who files with the Department a 
8notarized attestation of completion of at least 250 hours of 
9continuing education or training and at least 2,000 hours of 
10clinical experience after first attaining national 
11certification shall not require a written collaborative 
12agreement. Documentation of successful completion shall be 
13provided to the Department upon request.
14 (c) The scope of practice of a physician assistant with 
15optimal practice includes:
16  (1) all matters defined as physician assistant 
17 practice;
18  (2) practicing without a written collaborative 
19 agreement in all practice settings consistent with this 
20 Act;
21  (3) authority to prescribe both legend drugs and 
22 Schedule II through V controlled substances, including 
23 prescription of, selection of, orders for, administration 
24 of, storage of, acceptance of samples of, and dispensing 
25 over-the-counter medications, legend drugs, and controlled 
 
 
SB3114- 37 -LRB103 39234 SPS 69386 b


1 substances categorized as any Schedule II through V 
2 controlled substances, as defined in Article II of the 
3 Illinois Controlled Substances Act, and other 
4 preparations, including, but not limited to, botanical and 
5 herbal remedies; and
6  (4) authority to obtain an Illinois controlled 
7 substance license and a federal Drug Enforcement 
8 Administration number.
9 The scope of practice of a physician assistant does not 
10include operative surgery. Nothing in this Section shall be 
11construed to preclude a physician assistant from assisting in 
12surgery or performing other procedures as privileged by the 
13physician assistant's employer.
14 (d) The Department may adopt rules necessary to administer 
15this Section, including, but not limited to, requiring the 
16completion of forms and the payment of fees.
17 (e) Nothing in this Section shall be construed to prohibit 
18a physician assistant's employer from requiring a physician 
19assistant who satisfies the qualifications of subsection (b) 
20to practice with a written collaborative agreement.
21 (f) Nothing in this Act shall be construed to authorize a 
22physician assistant with optimal practice authority to provide 
23health care services required by law or rule to be performed by 
24a physician.

25 (225 ILCS 95/17) (from Ch. 111, par. 4617)
 
 
SB3114- 38 -LRB103 39234 SPS 69386 b


1 (Section scheduled to be repealed on January 1, 2028)
2 Sec. 17. Inactive status. Any physician assistant who 
3notified the Department in writing on forms prescribed by the 
4Department, may elect to place his or her license on an 
5inactive status and shall, subject to rules of the Department, 
6be excused from payment of renewal fees until he or she 
7notifies the Department in writing of his or her intention to 
8restore the license. Any person who holds an active license or 
9permit issued under the Medical Practice Act of 1987 shall 
10have that license or permit automatically placed into inactive 
11status upon issuance of a physician assistant license. Any 
12person who holds an active license as a physician assistant 
13who is issued a license or permit under the Medical Practice 
14Act of 1987 shall have the physician assistant license 
15automatically placed into inactive status.
16 Any physician assistant requesting restoration from 
17inactive status shall be required to pay the current renewal 
18fee and shall be required to restore his or her license, as 
19provided in Section 16 of this Act.
20 Any physician assistant whose license is in an inactive 
21status shall not practice in the State of Illinois.
22 Any licensee who shall engage in practice while his or her 
23license is lapsed or on inactive status shall be considered to 
24be practicing without a license, which shall be grounds for 
25discipline under Section 21 of this Act.
26(Source: P.A. 90-61, eff. 12-30-97.)

 
 
SB3114- 39 -LRB103 39234 SPS 69386 b


1 (225 ILCS 95/20) (from Ch. 111, par. 4620)
2 (Section scheduled to be repealed on January 1, 2028)
3 Sec. 20. Limitations. 
4 (a) No corporation, which stated purpose includes, or 
5which practices, or which holds itself out as available to 
6practice as a physician assistant or to practice any of the 
7functions described in Section 4 of this Act, shall be issued a 
8license by the Department, nor shall the Secretary of State 
9approve or accept articles of incorporation for such a 
10corporation.
11 (b) Pursuant to subparagraph (a) of paragraph (2) of 
12Section 3.6 of the Professional Service Corporation Act and 
13Section 2 of the Medical Corporation Act, a person licensed 
14under this Act may not own a corporation for the purposes of 
15practicing medicine.
16 (c) Pursuant to paragraph (2) of subsection (a) of Section 
1713 of the Professional Limited Liability Company Act, a person 
18licensed under this Act may not own a professional limited 
19liability company for the purposes of practicing medicine.
20(Source: P.A. 85-981.)

21 (225 ILCS 95/21) (from Ch. 111, par. 4621)
22 (Section scheduled to be repealed on January 1, 2028)
23 Sec. 21. Grounds for disciplinary action. 
24 (a) The Department may refuse to issue or to renew, or may 
 
 
SB3114- 40 -LRB103 39234 SPS 69386 b


1revoke, suspend, place on probation, reprimand, or take other 
2disciplinary or non-disciplinary action with regard to any 
3license issued under this Act as the Department may deem 
4proper, including the issuance of fines not to exceed $10,000 
5for each violation, for any one or combination of the 
6following causes:
7  (1) Material misstatement in furnishing information to 
8 the Department.
9  (2) Violations of this Act, or the rules adopted under 
10 this Act.
11  (3) Conviction by plea of guilty or nolo contendere, 
12 finding of guilt, jury verdict, or entry of judgment or 
13 sentencing, including, but not limited to, convictions, 
14 preceding sentences of supervision, conditional discharge, 
15 or first offender probation, under the laws of any 
16 jurisdiction of the United States that is: (i) a felony; 
17 or (ii) a misdemeanor, an essential element of which is 
18 dishonesty, or that is directly related to the practice of 
19 the profession.
20  (4) Making any misrepresentation for the purpose of 
21 obtaining licenses.
22  (5) Professional incompetence.
23  (6) Aiding or assisting another person in violating 
24 any provision of this Act or its rules.
25  (7) Failing, within 60 days, to provide information in 
26 response to a written request made by the Department.
 
 
SB3114- 41 -LRB103 39234 SPS 69386 b


1  (8) Engaging in dishonorable, unethical, or 
2 unprofessional conduct, as defined by rule, of a character 
3 likely to deceive, defraud, or harm the public.
4  (9) Habitual or excessive use or addiction to alcohol, 
5 narcotics, stimulants, or any other chemical agent or drug 
6 that results in a physician assistant's inability to 
7 practice with reasonable judgment, skill, or safety.
8  (10) Discipline by another U.S. jurisdiction or 
9 foreign nation, if at least one of the grounds for 
10 discipline is the same or substantially equivalent to 
11 those set forth in this Section.
12  (11) Directly or indirectly giving to or receiving 
13 from any person, firm, corporation, partnership, or 
14 association any fee, commission, rebate or other form of 
15 compensation for any professional services not actually or 
16 personally rendered. Nothing in this paragraph (11) 
17 affects any bona fide independent contractor or employment 
18 arrangements, which may include provisions for 
19 compensation, health insurance, pension, or other 
20 employment benefits, with persons or entities authorized 
21 under this Act for the provision of services within the 
22 scope of the licensee's practice under this Act.
23  (12) A finding by the Board that the licensee, after 
24 having his or her license placed on probationary status, 
25 has violated the terms of probation.
26  (13) Abandonment of a patient.
 
 
SB3114- 42 -LRB103 39234 SPS 69386 b


1  (14) Willfully making or filing false records or 
2 reports in his or her practice, including, but not limited 
3 to, false records filed with State agencies or 
4 departments.
5  (15) Willfully failing to report an instance of 
6 suspected child abuse or neglect as required by the Abused 
7 and Neglected Child Reporting Act.
8  (16) Physical illness, or mental illness or impairment 
9 that results in the inability to practice the profession 
10 with reasonable judgment, skill, or safety, including, but 
11 not limited to, deterioration through the aging process or 
12 loss of motor skill.
13  (17) Being named as a perpetrator in an indicated 
14 report by the Department of Children and Family Services 
15 under the Abused and Neglected Child Reporting Act, and 
16 upon proof by clear and convincing evidence that the 
17 licensee has caused a child to be an abused child or 
18 neglected child as defined in the Abused and Neglected 
19 Child Reporting Act.
20  (18) (Blank).
21  (19) Gross negligence resulting in permanent injury or 
22 death of a patient.
23  (20) Employment of fraud, deception or any unlawful 
24 means in applying for or securing a license as a physician 
25 assistant.
26  (21) Exceeding the authority delegated to him or her 
 
 
SB3114- 43 -LRB103 39234 SPS 69386 b


1 by his or her collaborating physician in a written 
2 collaborative agreement, when the agreement is required 
3 under this Act.
4  (22) Immoral conduct in the commission of any act, 
5 such as sexual abuse, sexual misconduct, or sexual 
6 exploitation related to the licensee's practice.
7  (23) Violation of the Health Care Worker Self-Referral 
8 Act.
9  (24) Practicing under a false or assumed name, except 
10 as provided by law.
11  (25) Making a false or misleading statement regarding 
12 his or her skill or the efficacy or value of the medicine, 
13 treatment, or remedy prescribed by him or her in the 
14 course of treatment.
15  (26) Allowing another person to use his or her license 
16 to practice.
17  (27) Prescribing, selling, administering, 
18 distributing, giving, or self-administering a drug 
19 classified as a controlled substance for other than 
20 medically accepted therapeutic purposes.
21  (28) Promotion of the sale of drugs, devices, 
22 appliances, or goods provided for a patient in a manner to 
23 exploit the patient for financial gain.
24  (29) A pattern of practice or other behavior that 
25 demonstrates incapacity or incompetence to practice under 
26 this Act.
 
 
SB3114- 44 -LRB103 39234 SPS 69386 b


1  (30) Violating State or federal laws or regulations 
2 relating to controlled substances or other legend drugs or 
3 ephedra as defined in the Ephedra Prohibition Act.
4  (31) (Blank). Exceeding the prescriptive authority 
5 delegated by the collaborating physician or violating the 
6 written collaborative agreement delegating that authority.
7  (32) (Blank). Practicing without providing to the 
8 Department a notice of collaboration or delegation of 
9 prescriptive authority.
10  (33) Failure to establish and maintain records of 
11 patient care and treatment as required by law.
12  (34) Attempting to subvert or cheat on the examination 
13 of the National Commission on Certification of Physician 
14 Assistants or its successor agency.
15  (35) Willfully or negligently violating the 
16 confidentiality between physician assistant and patient, 
17 except as required by law.
18  (36) Willfully failing to report an instance of 
19 suspected abuse, neglect, financial exploitation, or 
20 self-neglect of an eligible adult as defined in and 
21 required by the Adult Protective Services Act.
22  (37) Being named as an abuser in a verified report by 
23 the Department on Aging under the Adult Protective 
24 Services Act and upon proof by clear and convincing 
25 evidence that the licensee abused, neglected, or 
26 financially exploited an eligible adult as defined in the 
 
 
SB3114- 45 -LRB103 39234 SPS 69386 b


1 Adult Protective Services Act.
2  (38) Failure to report to the Department an adverse 
3 final action taken against him or her by another licensing 
4 jurisdiction of the United States or a foreign state or 
5 country, a peer review body, a health care institution, a 
6 professional society or association, a governmental 
7 agency, a law enforcement agency, or a court acts or 
8 conduct similar to acts or conduct that would constitute 
9 grounds for action under this Section.
10  (39) Failure to provide copies of records of patient 
11 care or treatment, except as required by law.
12  (40) (Blank). Entering into an excessive number of 
13 written collaborative agreements with licensed physicians 
14 resulting in an inability to adequately collaborate.
15  (41) (Blank). Repeated failure to adequately 
16 collaborate with a collaborating physician.
17  (42) Violating the Compassionate Use of Medical 
18 Cannabis Program Act. 
19 (b) The Department may, without a hearing, refuse to issue 
20or renew or may suspend the license of any person who fails to 
21file a return, or to pay the tax, penalty or interest shown in 
22a filed return, or to pay any final assessment of the tax, 
23penalty, or interest as required by any tax Act administered 
24by the Illinois Department of Revenue, until such time as the 
25requirements of any such tax Act are satisfied.
26 (b-5) The Department shall not revoke, suspend, summarily 
 
 
SB3114- 46 -LRB103 39234 SPS 69386 b


1suspend, place on prohibition, reprimand, refuse to issue or 
2renew, or take any other disciplinary or non-disciplinary 
3action against the license or permit issued under this Act to 
4practice as a physician assistant based solely upon the 
5physician assistant providing, authorizing, recommending, 
6aiding, assisting, referring for, or otherwise participating 
7in any health care service, so long as the care was not 
8unlawful under the laws of this State, regardless of whether 
9the patient was a resident of this State or another state.
10 (b-10) The Department shall not revoke, suspend, summarily 
11suspend, place on prohibition, reprimand, refuse to issue or 
12renew, or take any other disciplinary or non-disciplinary 
13action against the license or permit issued under this Act to 
14practice as a physician assistant based upon the physician 
15assistant's license being revoked or suspended, or the 
16physician assistant being otherwise disciplined by any other 
17state, if that revocation, suspension, or other form of 
18discipline was based solely on the physician assistant 
19violating another state's laws prohibiting the provision of, 
20authorization of, recommendation of, aiding or assisting in, 
21referring for, or participation in any health care service if 
22that health care service as provided would not have been 
23unlawful under the laws of this State and is consistent with 
24the standards of conduct for a physician assistant practicing 
25in Illinois.
26 (b-15) The conduct specified in subsections (b-5) and 
 
 
SB3114- 47 -LRB103 39234 SPS 69386 b


1(b-10) shall not constitute grounds for suspension under 
2Section 22.13.
3 (b-20) An applicant seeking licensure, certification, or 
4authorization pursuant to this Act who has been subject to 
5disciplinary action by a duly authorized professional 
6disciplinary agency of another jurisdiction solely on the 
7basis of having provided, authorized, recommended, aided, 
8assisted, referred for, or otherwise participated in health 
9care shall not be denied such licensure, certification, or 
10authorization, unless the Department determines that such 
11action would have constituted professional misconduct in this 
12State; however, nothing in this Section shall be construed as 
13prohibiting the Department from evaluating the conduct of such 
14applicant and making a determination regarding the licensure, 
15certification, or authorization to practice a profession under 
16this Act.
17 (c) The determination by a circuit court that a licensee 
18is subject to involuntary admission or judicial admission as 
19provided in the Mental Health and Developmental Disabilities 
20Code operates as an automatic suspension. The suspension will 
21end only upon a finding by a court that the patient is no 
22longer subject to involuntary admission or judicial admission 
23and issues an order so finding and discharging the patient, 
24and upon the recommendation of the Board to the Secretary that 
25the licensee be allowed to resume his or her practice.
26 (d) In enforcing this Section, the Department upon a 
 
 
SB3114- 48 -LRB103 39234 SPS 69386 b


1showing of a possible violation may compel an individual 
2licensed to practice under this Act, or who has applied for 
3licensure under this Act, to submit to a mental or physical 
4examination, or both, which may include a substance abuse or 
5sexual offender evaluation, as required by and at the expense 
6of the Department.
7 The Department shall specifically designate the examining 
8physician licensed to practice medicine in all of its branches 
9or, if applicable, the multidisciplinary team involved in 
10providing the mental or physical examination or both. The 
11multidisciplinary team shall be led by a physician licensed to 
12practice medicine in all of its branches and may consist of one 
13or more or a combination of physicians licensed to practice 
14medicine in all of its branches, licensed clinical 
15psychologists, licensed clinical social workers, licensed 
16clinical professional counselors, and other professional and 
17administrative staff. Any examining physician or member of the 
18multidisciplinary team may require any person ordered to 
19submit to an examination pursuant to this Section to submit to 
20any additional supplemental testing deemed necessary to 
21complete any examination or evaluation process, including, but 
22not limited to, blood testing, urinalysis, psychological 
23testing, or neuropsychological testing.
24 The Department may order the examining physician or any 
25member of the multidisciplinary team to provide to the 
26Department any and all records, including business records, 
 
 
SB3114- 49 -LRB103 39234 SPS 69386 b


1that relate to the examination and evaluation, including any 
2supplemental testing performed.
3 The Department may order the examining physician or any 
4member of the multidisciplinary team to present testimony 
5concerning the mental or physical examination of the licensee 
6or applicant. No information, report, record, or other 
7documents in any way related to the examination shall be 
8excluded by reason of any common law or statutory privilege 
9relating to communications between the licensee or applicant 
10and the examining physician or any member of the 
11multidisciplinary team. No authorization is necessary from the 
12licensee or applicant ordered to undergo an examination for 
13the examining physician or any member of the multidisciplinary 
14team to provide information, reports, records, or other 
15documents or to provide any testimony regarding the 
16examination and evaluation.
17 The individual to be examined may have, at his or her own 
18expense, another physician of his or her choice present during 
19all aspects of this examination. However, that physician shall 
20be present only to observe and may not interfere in any way 
21with the examination.
22  Failure of an individual to submit to a mental or physical 
23examination, when ordered, shall result in an automatic 
24suspension of his or her license until the individual submits 
25to the examination.
26 If the Department finds an individual unable to practice 
 
 
SB3114- 50 -LRB103 39234 SPS 69386 b


1because of the reasons set forth in this Section, the 
2Department may require that individual to submit to care, 
3counseling, or treatment by physicians approved or designated 
4by the Department, as a condition, term, or restriction for 
5continued, reinstated, or renewed licensure to practice; or, 
6in lieu of care, counseling, or treatment, the Department may 
7file a complaint to immediately suspend, revoke, or otherwise 
8discipline the license of the individual. An individual whose 
9license was granted, continued, reinstated, renewed, 
10disciplined, or supervised subject to such terms, conditions, 
11or restrictions, and who fails to comply with such terms, 
12conditions, or restrictions, shall be referred to the 
13Secretary for a determination as to whether the individual 
14shall have his or her license suspended immediately, pending a 
15hearing by the Department.
16 In instances in which the Secretary immediately suspends a 
17person's license under this Section, a hearing on that 
18person's license must be convened by the Department within 30 
19days after the suspension and completed without appreciable 
20delay. The Department shall have the authority to review the 
21subject individual's record of treatment and counseling 
22regarding the impairment to the extent permitted by applicable 
23federal statutes and regulations safeguarding the 
24confidentiality of medical records.
25 An individual licensed under this Act and affected under 
26this Section shall be afforded an opportunity to demonstrate 
 
 
SB3114- 51 -LRB103 39234 SPS 69386 b


1to the Department that he or she can resume practice in 
2compliance with acceptable and prevailing standards under the 
3provisions of his or her license.
4 (e) An individual or organization acting in good faith, 
5and not in a willful and wanton manner, in complying with this 
6Section by providing a report or other information to the 
7Board, by assisting in the investigation or preparation of a 
8report or information, by participating in proceedings of the 
9Board, or by serving as a member of the Board, shall not be 
10subject to criminal prosecution or civil damages as a result 
11of such actions.
12 (f) Members of the Board shall be indemnified by the State 
13for any actions occurring within the scope of services on the 
14Board, done in good faith and not willful and wanton in nature. 
15The Attorney General shall defend all such actions unless he 
16or she determines either that there would be a conflict of 
17interest in such representation or that the actions complained 
18of were not in good faith or were willful and wanton.
19 If the Attorney General declines representation, the 
20member has the right to employ counsel of his or her choice, 
21whose fees shall be provided by the State, after approval by 
22the Attorney General, unless there is a determination by a 
23court that the member's actions were not in good faith or were 
24willful and wanton.
25 The member must notify the Attorney General within 7 days 
26after receipt of notice of the initiation of any action 
 
 
SB3114- 52 -LRB103 39234 SPS 69386 b


1involving services of the Board. Failure to so notify the 
2Attorney General constitutes an absolute waiver of the right 
3to a defense and indemnification.
4 The Attorney General shall determine, within 7 days after 
5receiving such notice, whether he or she will undertake to 
6represent the member. 
7 (g) The Department may adopt rules to implement the 
8changes made by this amendatory Act of the 102nd General 
9Assembly.
10(Source: P.A. 101-363, eff. 8-9-19; 102-558, eff. 8-20-21; 
11102-1117, eff. 1-13-23.)

12 Section 10. The Illinois Controlled Substances Act is 
13amended by changing Sections 102 and 303.05 as follows:

14 (720 ILCS 570/102) (from Ch. 56 1/2, par. 1102)
15 Sec. 102. Definitions.  As used in this Act, unless the 
16context otherwise requires: 
17 (a) "Addict" means any person who habitually uses any 
18drug, chemical, substance or dangerous drug other than alcohol 
19so as to endanger the public morals, health, safety or welfare 
20or who is so far addicted to the use of a dangerous drug or 
21controlled substance other than alcohol as to have lost the 
22power of self control with reference to his or her addiction.
23 (b) "Administer" means the direct application of a 
24controlled substance, whether by injection, inhalation, 
 
 
SB3114- 53 -LRB103 39234 SPS 69386 b


1ingestion, or any other means, to the body of a patient, 
2research subject, or animal (as defined by the Humane 
3Euthanasia in Animal Shelters Act) by:
4  (1) a practitioner (or, in his or her presence, by his 
5 or her authorized agent),
6  (2) the patient or research subject pursuant to an 
7 order, or
8  (3) a euthanasia technician as defined by the Humane 
9 Euthanasia in Animal Shelters Act.
10 (c) "Agent" means an authorized person who acts on behalf 
11of or at the direction of a manufacturer, distributor, 
12dispenser, prescriber, or practitioner. It does not include a 
13common or contract carrier, public warehouseman or employee of 
14the carrier or warehouseman.
15 (c-1) "Anabolic Steroids" means any drug or hormonal 
16substance, chemically and pharmacologically related to 
17testosterone (other than estrogens, progestins, 
18corticosteroids, and dehydroepiandrosterone), and includes:
19 (i) 3[beta],17-dihydroxy-5a-androstane, 
20 (ii) 3[alpha],17[beta]-dihydroxy-5a-androstane, 
21 (iii) 5[alpha]-androstan-3,17-dione, 
22 (iv) 1-androstenediol (3[beta], 
23  17[beta]-dihydroxy-5[alpha]-androst-1-ene), 
24 (v) 1-androstenediol (3[alpha], 
25  17[beta]-dihydroxy-5[alpha]-androst-1-ene), 
26 (vi) 4-androstenediol 
 
 
SB3114- 54 -LRB103 39234 SPS 69386 b


1  (3[beta],17[beta]-dihydroxy-androst-4-ene), 
2 (vii) 5-androstenediol 
3  (3[beta],17[beta]-dihydroxy-androst-5-ene), 
4 (viii) 1-androstenedione 
5  ([5alpha]-androst-1-en-3,17-dione), 
6 (ix) 4-androstenedione 
7  (androst-4-en-3,17-dione), 
8 (x) 5-androstenedione 
9  (androst-5-en-3,17-dione), 
10 (xi) bolasterone (7[alpha],17a-dimethyl-17[beta]- 
11  hydroxyandrost-4-en-3-one), 
12 (xii) boldenone (17[beta]-hydroxyandrost- 
13  1,4,-diene-3-one), 
14 (xiii) boldione (androsta-1,4- 
15  diene-3,17-dione), 
16 (xiv) calusterone (7[beta],17[alpha]-dimethyl-17 
17  [beta]-hydroxyandrost-4-en-3-one), 
18 (xv) clostebol (4-chloro-17[beta]- 
19  hydroxyandrost-4-en-3-one), 
20 (xvi) dehydrochloromethyltestosterone (4-chloro- 
21  17[beta]-hydroxy-17[alpha]-methyl- 
22  androst-1,4-dien-3-one), 
23 (xvii) desoxymethyltestosterone 
24 (17[alpha]-methyl-5[alpha] 
25  -androst-2-en-17[beta]-ol)(a.k.a., madol), 
26 (xviii) [delta]1-dihydrotestosterone (a.k.a. 
 
 
SB3114- 55 -LRB103 39234 SPS 69386 b


1  '1-testosterone') (17[beta]-hydroxy- 
2  5[alpha]-androst-1-en-3-one), 
3 (xix) 4-dihydrotestosterone (17[beta]-hydroxy- 
4  androstan-3-one), 
5 (xx) drostanolone (17[beta]-hydroxy-2[alpha]-methyl- 
6  5[alpha]-androstan-3-one), 
7 (xxi) ethylestrenol (17[alpha]-ethyl-17[beta]- 
8  hydroxyestr-4-ene), 
9 (xxii) fluoxymesterone (9-fluoro-17[alpha]-methyl- 
10  1[beta],17[beta]-dihydroxyandrost-4-en-3-one), 
11 (xxiii) formebolone (2-formyl-17[alpha]-methyl-11[alpha], 
12  17[beta]-dihydroxyandrost-1,4-dien-3-one), 
13 (xxiv) furazabol (17[alpha]-methyl-17[beta]- 
14  hydroxyandrostano[2,3-c]-furazan), 
15 (xxv) 13[beta]-ethyl-17[beta]-hydroxygon-4-en-3-one, 
16 (xxvi) 4-hydroxytestosterone (4,17[beta]-dihydroxy- 
17  androst-4-en-3-one), 
18 (xxvii) 4-hydroxy-19-nortestosterone (4,17[beta]- 
19  dihydroxy-estr-4-en-3-one), 
20 (xxviii) mestanolone (17[alpha]-methyl-17[beta]- 
21  hydroxy-5-androstan-3-one), 
22 (xxix) mesterolone (1amethyl-17[beta]-hydroxy- 
23  [5a]-androstan-3-one), 
24 (xxx) methandienone (17[alpha]-methyl-17[beta]- 
25  hydroxyandrost-1,4-dien-3-one), 
26 (xxxi) methandriol (17[alpha]-methyl-3[beta],17[beta]- 
 
 
SB3114- 56 -LRB103 39234 SPS 69386 b


1  dihydroxyandrost-5-ene), 
2 (xxxii) methenolone (1-methyl-17[beta]-hydroxy- 
3  5[alpha]-androst-1-en-3-one), 
4 (xxxiii) 17[alpha]-methyl-3[beta], 17[beta]- 
5  dihydroxy-5a-androstane, 
6 (xxxiv) 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy 
7  -5a-androstane, 
8 (xxxv) 17[alpha]-methyl-3[beta],17[beta]- 
9  dihydroxyandrost-4-ene), 
10 (xxxvi) 17[alpha]-methyl-4-hydroxynandrolone (17[alpha]- 
11  methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one), 
12 (xxxvii) methyldienolone (17[alpha]-methyl-17[beta]- 
13  hydroxyestra-4,9(10)-dien-3-one), 
14 (xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]- 
15  hydroxyestra-4,9-11-trien-3-one), 
16 (xxxix) methyltestosterone (17[alpha]-methyl-17[beta]- 
17  hydroxyandrost-4-en-3-one), 
18 (xl) mibolerone (7[alpha],17a-dimethyl-17[beta]- 
19  hydroxyestr-4-en-3-one), 
20 (xli) 17[alpha]-methyl-[delta]1-dihydrotestosterone 
21  (17b[beta]-hydroxy-17[alpha]-methyl-5[alpha]- 
22  androst-1-en-3-one)(a.k.a. '17-[alpha]-methyl- 
23  1-testosterone'), 
24 (xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one), 
25 (xliii) 19-nor-4-androstenediol (3[beta], 17[beta]- 
26  dihydroxyestr-4-ene), 
 
 
SB3114- 57 -LRB103 39234 SPS 69386 b


1 (xliv) 19-nor-4-androstenediol (3[alpha], 17[beta]- 
2  dihydroxyestr-4-ene), 
3 (xlv) 19-nor-5-androstenediol (3[beta], 17[beta]- 
4  dihydroxyestr-5-ene), 
5 (xlvi) 19-nor-5-androstenediol (3[alpha], 17[beta]- 
6  dihydroxyestr-5-ene), 
7 (xlvii) 19-nor-4,9(10)-androstadienedione 
8  (estra-4,9(10)-diene-3,17-dione), 
9 (xlviii) 19-nor-4-androstenedione (estr-4- 
10  en-3,17-dione), 
11 (xlix) 19-nor-5-androstenedione (estr-5- 
12  en-3,17-dione), 
13 (l) norbolethone (13[beta], 17a-diethyl-17[beta]- 
14  hydroxygon-4-en-3-one), 
15 (li) norclostebol (4-chloro-17[beta]- 
16  hydroxyestr-4-en-3-one), 
17 (lii) norethandrolone (17[alpha]-ethyl-17[beta]- 
18  hydroxyestr-4-en-3-one), 
19 (liii) normethandrolone (17[alpha]-methyl-17[beta]- 
20  hydroxyestr-4-en-3-one), 
21 (liv) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy- 
22  2-oxa-5[alpha]-androstan-3-one), 
23 (lv) oxymesterone (17[alpha]-methyl-4,17[beta]- 
24  dihydroxyandrost-4-en-3-one), 
25 (lvi) oxymetholone (17[alpha]-methyl-2-hydroxymethylene- 
26  17[beta]-hydroxy-(5[alpha]-androstan-3-one), 
 
 
SB3114- 58 -LRB103 39234 SPS 69386 b


1 (lvii) stanozolol (17[alpha]-methyl-17[beta]-hydroxy- 
2  (5[alpha]-androst-2-eno[3,2-c]-pyrazole), 
3 (lviii) stenbolone (17[beta]-hydroxy-2-methyl- 
4  (5[alpha]-androst-1-en-3-one), 
5 (lix) testolactone (13-hydroxy-3-oxo-13,17- 
6  secoandrosta-1,4-dien-17-oic 
7  acid lactone), 
8 (lx) testosterone (17[beta]-hydroxyandrost- 
9  4-en-3-one), 
10 (lxi) tetrahydrogestrinone (13[beta], 17[alpha]- 
11  diethyl-17[beta]-hydroxygon- 
12  4,9,11-trien-3-one), 
13 (lxii) trenbolone (17[beta]-hydroxyestr-4,9, 
14  11-trien-3-one). 
15 Any person who is otherwise lawfully in possession of an 
16anabolic steroid, or who otherwise lawfully manufactures, 
17distributes, dispenses, delivers, or possesses with intent to 
18deliver an anabolic steroid, which anabolic steroid is 
19expressly intended for and lawfully allowed to be administered 
20through implants to livestock or other nonhuman species, and 
21which is approved by the Secretary of Health and Human 
22Services for such administration, and which the person intends 
23to administer or have administered through such implants, 
24shall not be considered to be in unauthorized possession or to 
25unlawfully manufacture, distribute, dispense, deliver, or 
26possess with intent to deliver such anabolic steroid for 
 
 
SB3114- 59 -LRB103 39234 SPS 69386 b


1purposes of this Act.
2 (d) "Administration" means the Drug Enforcement 
3Administration, United States Department of Justice, or its 
4successor agency.
5 (d-5) "Clinical Director, Prescription Monitoring Program" 
6means a Department of Human Services administrative employee 
7licensed to either prescribe or dispense controlled substances 
8who shall run the clinical aspects of the Department of Human 
9Services Prescription Monitoring Program and its Prescription 
10Information Library.
11 (d-10) "Compounding" means the preparation and mixing of 
12components, excluding flavorings, (1) as the result of a 
13prescriber's prescription drug order or initiative based on 
14the prescriber-patient-pharmacist relationship in the course 
15of professional practice or (2) for the purpose of, or 
16incident to, research, teaching, or chemical analysis and not 
17for sale or dispensing. "Compounding" includes the preparation 
18of drugs or devices in anticipation of receiving prescription 
19drug orders based on routine, regularly observed dispensing 
20patterns. Commercially available products may be compounded 
21for dispensing to individual patients only if both of the 
22following conditions are met: (i) the commercial product is 
23not reasonably available from normal distribution channels in 
24a timely manner to meet the patient's needs and (ii) the 
25prescribing practitioner has requested that the drug be 
26compounded.
 
 
SB3114- 60 -LRB103 39234 SPS 69386 b


1 (e) "Control" means to add a drug or other substance, or 
2immediate precursor, to a Schedule whether by transfer from 
3another Schedule or otherwise. 
4 (f) "Controlled Substance" means (i) a drug, substance, 
5immediate precursor, or synthetic drug in the Schedules of 
6Article II of this Act or (ii) a drug or other substance, or 
7immediate precursor, designated as a controlled substance by 
8the Department through administrative rule. The term does not 
9include distilled spirits, wine, malt beverages, or tobacco, 
10as those terms are defined or used in the Liquor Control Act of 
111934 and the Tobacco Products Tax Act of 1995. 
12 (f-5) "Controlled substance analog" means a substance:
13  (1) the chemical structure of which is substantially 
14 similar to the chemical structure of a controlled 
15 substance in Schedule I or II;
16  (2) which has a stimulant, depressant, or 
17 hallucinogenic effect on the central nervous system that 
18 is substantially similar to or greater than the stimulant, 
19 depressant, or hallucinogenic effect on the central 
20 nervous system of a controlled substance in Schedule I or 
21 II; or
22  (3) with respect to a particular person, which such 
23 person represents or intends to have a stimulant, 
24 depressant, or hallucinogenic effect on the central 
25 nervous system that is substantially similar to or greater 
26 than the stimulant, depressant, or hallucinogenic effect 
 
 
SB3114- 61 -LRB103 39234 SPS 69386 b


1 on the central nervous system of a controlled substance in 
2 Schedule I or II. 
3 (g) "Counterfeit substance" means a controlled substance, 
4which, or the container or labeling of which, without 
5authorization bears the trademark, trade name, or other 
6identifying mark, imprint, number or device, or any likeness 
7thereof, of a manufacturer, distributor, or dispenser other 
8than the person who in fact manufactured, distributed, or 
9dispensed the substance. 
10 (h) "Deliver" or "delivery" means the actual, constructive 
11or attempted transfer of possession of a controlled substance, 
12with or without consideration, whether or not there is an 
13agency relationship. "Deliver" or "delivery" does not include 
14the donation of drugs to the extent permitted under the 
15Illinois Drug Reuse Opportunity Program Act. 
16 (i) "Department" means the Illinois Department of Human 
17Services (as successor to the Department of Alcoholism and 
18Substance Abuse) or its successor agency. 
19 (j) (Blank). 
20 (k) "Department of Corrections" means the Department of 
21Corrections of the State of Illinois or its successor agency. 
22 (l) "Department of Financial and Professional Regulation" 
23means the Department of Financial and Professional Regulation 
24of the State of Illinois or its successor agency. 
25 (m) "Depressant" means any drug that (i) causes an overall 
26depression of central nervous system functions, (ii) causes 
 
 
SB3114- 62 -LRB103 39234 SPS 69386 b


1impaired consciousness and awareness, and (iii) can be 
2habit-forming or lead to a substance abuse problem, including, 
3but not limited to, alcohol, cannabis and its active 
4principles and their analogs, benzodiazepines and their 
5analogs, barbiturates and their analogs, opioids (natural and 
6synthetic) and their analogs, and chloral hydrate and similar 
7sedative hypnotics. 
8 (n) (Blank). 
9 (o) "Director" means the Director of the Illinois State 
10Police or his or her designated agents. 
11 (p) "Dispense" means to deliver a controlled substance to 
12an ultimate user or research subject by or pursuant to the 
13lawful order of a prescriber, including the prescribing, 
14administering, packaging, labeling, or compounding necessary 
15to prepare the substance for that delivery. 
16 (q) "Dispenser" means a practitioner who dispenses. 
17 (r) "Distribute" means to deliver, other than by 
18administering or dispensing, a controlled substance. 
19 (s) "Distributor" means a person who distributes. 
20 (t) "Drug" means (1) substances recognized as drugs in the 
21official United States Pharmacopoeia, Official Homeopathic 
22Pharmacopoeia of the United States, or official National 
23Formulary, or any supplement to any of them; (2) substances 
24intended for use in diagnosis, cure, mitigation, treatment, or 
25prevention of disease in man or animals; (3) substances (other 
26than food) intended to affect the structure of any function of 
 
 
SB3114- 63 -LRB103 39234 SPS 69386 b


1the body of man or animals and (4) substances intended for use 
2as a component of any article specified in clause (1), (2), or 
3(3) of this subsection. It does not include devices or their 
4components, parts, or accessories. 
5 (t-3) "Electronic health record" or "EHR" means an 
6electronic record of health-related information on an 
7individual that is created, gathered, managed, and consulted 
8by authorized health care clinicians and staff. 
9 (t-3.5) "Electronic health record system" or "EHR system" 
10means any computer-based system or combination of federally 
11certified Health IT Modules (defined at 42 CFR 170.102 or its 
12successor) used as a repository for electronic health records 
13and accessed or updated by a prescriber or authorized 
14surrogate in the ordinary course of his or her medical 
15practice. For purposes of connecting to the Prescription 
16Information Library maintained by the Bureau of Pharmacy and 
17Clinical Support Systems or its successor, an EHR system may 
18connect to the Prescription Information Library directly or 
19through all or part of a computer program or system that is a 
20federally certified Health IT Module maintained by a third 
21party and used by the EHR system to secure access to the 
22database.
23 (t-4) "Emergency medical services personnel" has the 
24meaning ascribed to it in the Emergency Medical Services (EMS) 
25Systems Act.
26 (t-5) "Euthanasia agency" means an entity certified by the 
 
 
SB3114- 64 -LRB103 39234 SPS 69386 b


1Department of Financial and Professional Regulation for the 
2purpose of animal euthanasia that holds an animal control 
3facility license or animal shelter license under the Animal 
4Welfare Act. A euthanasia agency is authorized to purchase, 
5store, possess, and utilize Schedule II nonnarcotic and 
6Schedule III nonnarcotic drugs for the sole purpose of animal 
7euthanasia. 
8 (t-10) "Euthanasia drugs" means Schedule II or Schedule 
9III substances (nonnarcotic controlled substances) that are 
10used by a euthanasia agency for the purpose of animal 
11euthanasia. 
12 (u) "Good faith" means the prescribing or dispensing of a 
13controlled substance by a practitioner in the regular course 
14of professional treatment to or for any person who is under his 
15or her treatment for a pathology or condition other than that 
16individual's physical or psychological dependence upon or 
17addiction to a controlled substance, except as provided 
18herein: and application of the term to a pharmacist shall mean 
19the dispensing of a controlled substance pursuant to the 
20prescriber's order which in the professional judgment of the 
21pharmacist is lawful. The pharmacist shall be guided by 
22accepted professional standards, including, but not limited 
23to, the following, in making the judgment: 
24  (1) lack of consistency of prescriber-patient 
25 relationship, 
26  (2) frequency of prescriptions for same drug by one 
 
 
SB3114- 65 -LRB103 39234 SPS 69386 b


1 prescriber for large numbers of patients, 
2  (3) quantities beyond those normally prescribed, 
3  (4) unusual dosages (recognizing that there may be 
4 clinical circumstances where more or less than the usual 
5 dose may be used legitimately), 
6  (5) unusual geographic distances between patient, 
7 pharmacist and prescriber, 
8  (6) consistent prescribing of habit-forming drugs. 
9 (u-0.5) "Hallucinogen" means a drug that causes markedly 
10altered sensory perception leading to hallucinations of any 
11type. 
12 (u-1) "Home infusion services" means services provided by 
13a pharmacy in compounding solutions for direct administration 
14to a patient in a private residence, long-term care facility, 
15or hospice setting by means of parenteral, intravenous, 
16intramuscular, subcutaneous, or intraspinal infusion. 
17 (u-5) "Illinois State Police" means the Illinois State 
18Police or its successor agency. 
19 (v) "Immediate precursor" means a substance: 
20  (1) which the Department has found to be and by rule 
21 designated as being a principal compound used, or produced 
22 primarily for use, in the manufacture of a controlled 
23 substance; 
24  (2) which is an immediate chemical intermediary used 
25 or likely to be used in the manufacture of such controlled 
26 substance; and 
 
 
SB3114- 66 -LRB103 39234 SPS 69386 b


1  (3) the control of which is necessary to prevent, 
2 curtail or limit the manufacture of such controlled 
3 substance. 
4 (w) "Instructional activities" means the acts of teaching, 
5educating or instructing by practitioners using controlled 
6substances within educational facilities approved by the State 
7Board of Education or its successor agency. 
8 (x) "Local authorities" means a duly organized State, 
9County or Municipal peace unit or police force. 
10 (y) "Look-alike substance" means a substance, other than a 
11controlled substance which (1) by overall dosage unit 
12appearance, including shape, color, size, markings or lack 
13thereof, taste, consistency, or any other identifying physical 
14characteristic of the substance, would lead a reasonable 
15person to believe that the substance is a controlled 
16substance, or (2) is expressly or impliedly represented to be 
17a controlled substance or is distributed under circumstances 
18which would lead a reasonable person to believe that the 
19substance is a controlled substance. For the purpose of 
20determining whether the representations made or the 
21circumstances of the distribution would lead a reasonable 
22person to believe the substance to be a controlled substance 
23under this clause (2) of subsection (y), the court or other 
24authority may consider the following factors in addition to 
25any other factor that may be relevant: 
26  (a) statements made by the owner or person in control 
 
 
SB3114- 67 -LRB103 39234 SPS 69386 b


1 of the substance concerning its nature, use or effect; 
2  (b) statements made to the buyer or recipient that the 
3 substance may be resold for profit; 
4  (c) whether the substance is packaged in a manner 
5 normally used for the illegal distribution of controlled 
6 substances; 
7  (d) whether the distribution or attempted distribution 
8 included an exchange of or demand for money or other 
9 property as consideration, and whether the amount of the 
10 consideration was substantially greater than the 
11 reasonable retail market value of the substance. 
12 Clause (1) of this subsection (y) shall not apply to a 
13noncontrolled substance in its finished dosage form that was 
14initially introduced into commerce prior to the initial 
15introduction into commerce of a controlled substance in its 
16finished dosage form which it may substantially resemble. 
17 Nothing in this subsection (y) prohibits the dispensing or 
18distributing of noncontrolled substances by persons authorized 
19to dispense and distribute controlled substances under this 
20Act, provided that such action would be deemed to be carried 
21out in good faith under subsection (u) if the substances 
22involved were controlled substances. 
23 Nothing in this subsection (y) or in this Act prohibits 
24the manufacture, preparation, propagation, compounding, 
25processing, packaging, advertising or distribution of a drug 
26or drugs by any person registered pursuant to Section 510 of 
 
 
SB3114- 68 -LRB103 39234 SPS 69386 b


1the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360). 
2 (y-1) "Mail-order pharmacy" means a pharmacy that is 
3located in a state of the United States that delivers, 
4dispenses or distributes, through the United States Postal 
5Service or other common carrier, to Illinois residents, any 
6substance which requires a prescription. 
7 (z) "Manufacture" means the production, preparation, 
8propagation, compounding, conversion or processing of a 
9controlled substance other than methamphetamine, either 
10directly or indirectly, by extraction from substances of 
11natural origin, or independently by means of chemical 
12synthesis, or by a combination of extraction and chemical 
13synthesis, and includes any packaging or repackaging of the 
14substance or labeling of its container, except that this term 
15does not include: 
16  (1) by an ultimate user, the preparation or 
17 compounding of a controlled substance for his or her own 
18 use; 
19  (2) by a practitioner, or his or her authorized agent 
20 under his or her supervision, the preparation, 
21 compounding, packaging, or labeling of a controlled 
22 substance: 
23   (a) as an incident to his or her administering or 
24 dispensing of a controlled substance in the course of 
25 his or her professional practice; or 
26   (b) as an incident to lawful research, teaching or 
 
 
SB3114- 69 -LRB103 39234 SPS 69386 b


1 chemical analysis and not for sale; or 
2  (3) the packaging, repackaging, or labeling of drugs 
3 only to the extent permitted under the Illinois Drug Reuse 
4 Opportunity Program Act. 
5 (z-1) (Blank). 
6 (z-5) "Medication shopping" means the conduct prohibited 
7under subsection (a) of Section 314.5 of this Act.
8 (z-10) "Mid-level practitioner" means (i) a physician 
9assistant who has been delegated authority to prescribe 
10through a written delegation of authority by a physician 
11licensed to practice medicine in all of its branches, in 
12accordance with Section 7.5 of the Physician Assistant 
13Practice Act of 1987, (ii) an advanced practice registered 
14nurse who has been delegated authority to prescribe through a 
15written delegation of authority by a physician licensed to 
16practice medicine in all of its branches or by a podiatric 
17physician, in accordance with Section 65-40 of the Nurse 
18Practice Act, (iii) an advanced practice registered nurse 
19certified as a nurse practitioner, nurse midwife, or clinical 
20nurse specialist who has been granted authority to prescribe 
21by a hospital affiliate in accordance with Section 65-45 of 
22the Nurse Practice Act, (iv) an animal euthanasia agency, or 
23(v) a prescribing psychologist. 
24 (aa) "Narcotic drug" means any of the following, whether 
25produced directly or indirectly by extraction from substances 
26of vegetable origin, or independently by means of chemical 
 
 
SB3114- 70 -LRB103 39234 SPS 69386 b


1synthesis, or by a combination of extraction and chemical 
2synthesis: 
3  (1) opium, opiates, derivatives of opium and opiates, 
4 including their isomers, esters, ethers, salts, and salts 
5 of isomers, esters, and ethers, whenever the existence of 
6 such isomers, esters, ethers, and salts is possible within 
7 the specific chemical designation; however the term 
8 "narcotic drug" does not include the isoquinoline 
9 alkaloids of opium; 
10  (2) (blank); 
11  (3) opium poppy and poppy straw; 
12  (4) coca leaves, except coca leaves and extracts of 
13 coca leaves from which substantially all of the cocaine 
14 and ecgonine, and their isomers, derivatives and salts, 
15 have been removed; 
16  (5) cocaine, its salts, optical and geometric isomers, 
17 and salts of isomers;
18  (6) ecgonine, its derivatives, their salts, isomers, 
19 and salts of isomers;
20  (7) any compound, mixture, or preparation which 
21 contains any quantity of any of the substances referred to 
22 in subparagraphs (1) through (6). 
23 (bb) "Nurse" means a registered nurse licensed under the 
24Nurse Practice Act. 
25 (cc) (Blank). 
26 (dd) "Opiate" means any substance having an addiction 
 
 
SB3114- 71 -LRB103 39234 SPS 69386 b


1forming or addiction sustaining liability similar to morphine 
2or being capable of conversion into a drug having addiction 
3forming or addiction sustaining liability. 
4 (ee) "Opium poppy" means the plant of the species Papaver 
5somniferum L., except its seeds. 
6 (ee-5) "Oral dosage" means a tablet, capsule, elixir, or 
7solution or other liquid form of medication intended for 
8administration by mouth, but the term does not include a form 
9of medication intended for buccal, sublingual, or transmucosal 
10administration. 
11 (ff) "Parole and Pardon Board" means the Parole and Pardon 
12Board of the State of Illinois or its successor agency. 
13 (gg) "Person" means any individual, corporation, 
14mail-order pharmacy, government or governmental subdivision or 
15agency, business trust, estate, trust, partnership or 
16association, or any other entity. 
17 (hh) "Pharmacist" means any person who holds a license or 
18certificate of registration as a registered pharmacist, a 
19local registered pharmacist or a registered assistant 
20pharmacist under the Pharmacy Practice Act. 
21 (ii) "Pharmacy" means any store, ship or other place in 
22which pharmacy is authorized to be practiced under the 
23Pharmacy Practice Act. 
24 (ii-5) "Pharmacy shopping" means the conduct prohibited 
25under subsection (b) of Section 314.5 of this Act.
26 (ii-10) "Physician" (except when the context otherwise 
 
 
SB3114- 72 -LRB103 39234 SPS 69386 b


1requires) means a person licensed to practice medicine in all 
2of its branches. 
3 (jj) "Poppy straw" means all parts, except the seeds, of 
4the opium poppy, after mowing. 
5 (kk) "Practitioner" means a physician licensed to practice 
6medicine in all its branches, dentist, optometrist, podiatric 
7physician, veterinarian, scientific investigator, pharmacist, 
8physician assistant, advanced practice registered nurse, 
9licensed practical nurse, registered nurse, emergency medical 
10services personnel, hospital, laboratory, or pharmacy, or 
11other person licensed, registered, or otherwise lawfully 
12permitted by the United States or this State to distribute, 
13dispense, conduct research with respect to, administer or use 
14in teaching or chemical analysis, a controlled substance in 
15the course of professional practice or research. 
16 (ll) "Pre-printed prescription" means a written 
17prescription upon which the designated drug has been indicated 
18prior to the time of issuance; the term does not mean a written 
19prescription that is individually generated by machine or 
20computer in the prescriber's office. 
21 (mm) "Prescriber" means a physician licensed to practice 
22medicine in all its branches, dentist, optometrist, 
23prescribing psychologist licensed under Section 4.2 of the 
24Clinical Psychologist Licensing Act with prescriptive 
25authority delegated under Section 4.3 of the Clinical 
26Psychologist Licensing Act, podiatric physician, or 
 
 
SB3114- 73 -LRB103 39234 SPS 69386 b


1veterinarian who issues a prescription, a physician assistant 
2who issues a prescription for a controlled substance in 
3accordance with Section 303.05, a written delegation, and a 
4written collaborative agreement required under Section 7.5 of 
5the Physician Assistant Practice Act of 1987, an advanced 
6practice registered nurse with prescriptive authority 
7delegated under Section 65-40 of the Nurse Practice Act and in 
8accordance with Section 303.05, a written delegation, and a 
9written collaborative agreement under Section 65-35 of the 
10Nurse Practice Act, an advanced practice registered nurse 
11certified as a nurse practitioner, nurse midwife, or clinical 
12nurse specialist who has been granted authority to prescribe 
13by a hospital affiliate in accordance with Section 65-45 of 
14the Nurse Practice Act and in accordance with Section 303.05, 
15or an advanced practice registered nurse certified as a nurse 
16practitioner, nurse midwife, or clinical nurse specialist who 
17has full practice authority pursuant to Section 65-43 of the 
18Nurse Practice Act. 
19 (nn) "Prescription" means a written, facsimile, or oral 
20order, or an electronic order that complies with applicable 
21federal requirements, of a physician licensed to practice 
22medicine in all its branches, dentist, podiatric physician or 
23veterinarian for any controlled substance, of an optometrist 
24in accordance with Section 15.1 of the Illinois Optometric 
25Practice Act of 1987, of a prescribing psychologist licensed 
26under Section 4.2 of the Clinical Psychologist Licensing Act 
 
 
SB3114- 74 -LRB103 39234 SPS 69386 b


1with prescriptive authority delegated under Section 4.3 of the 
2Clinical Psychologist Licensing Act, of a physician assistant 
3for a controlled substance in accordance with Section 303.05, 
4a written delegation, and a written collaborative agreement 
5required under Section 7.5 of the Physician Assistant Practice 
6Act of 1987, of an advanced practice registered nurse with 
7prescriptive authority delegated under Section 65-40 of the 
8Nurse Practice Act who issues a prescription for a controlled 
9substance in accordance with Section 303.05, a written 
10delegation, and a written collaborative agreement under 
11Section 65-35 of the Nurse Practice Act, of an advanced 
12practice registered nurse certified as a nurse practitioner, 
13nurse midwife, or clinical nurse specialist who has been 
14granted authority to prescribe by a hospital affiliate in 
15accordance with Section 65-45 of the Nurse Practice Act and in 
16accordance with Section 303.05 when required by law, or of an 
17advanced practice registered nurse certified as a nurse 
18practitioner, nurse midwife, or clinical nurse specialist who 
19has full practice authority pursuant to Section 65-43 of the 
20Nurse Practice Act. 
21 (nn-5) "Prescription Information Library" (PIL) means an 
22electronic library that contains reported controlled substance 
23data.
24 (nn-10) "Prescription Monitoring Program" (PMP) means the 
25entity that collects, tracks, and stores reported data on 
26controlled substances and select drugs pursuant to Section 
 
 
SB3114- 75 -LRB103 39234 SPS 69386 b


1316. 
2 (oo) "Production" or "produce" means manufacture, 
3planting, cultivating, growing, or harvesting of a controlled 
4substance other than methamphetamine. 
5 (pp) "Registrant" means every person who is required to 
6register under Section 302 of this Act. 
7 (qq) "Registry number" means the number assigned to each 
8person authorized to handle controlled substances under the 
9laws of the United States and of this State. 
10 (qq-5) "Secretary" means, as the context requires, either 
11the Secretary of the Department or the Secretary of the 
12Department of Financial and Professional Regulation, and the 
13Secretary's designated agents. 
14 (rr) "State" includes the State of Illinois and any state, 
15district, commonwealth, territory, insular possession thereof, 
16and any area subject to the legal authority of the United 
17States of America. 
18 (rr-5) "Stimulant" means any drug that (i) causes an 
19overall excitation of central nervous system functions, (ii) 
20causes impaired consciousness and awareness, and (iii) can be 
21habit-forming or lead to a substance abuse problem, including, 
22but not limited to, amphetamines and their analogs, 
23methylphenidate and its analogs, cocaine, and phencyclidine 
24and its analogs. 
25 (rr-10) "Synthetic drug" includes, but is not limited to, 
26any synthetic cannabinoids or piperazines or any synthetic 
 
 
SB3114- 76 -LRB103 39234 SPS 69386 b


1cathinones as provided for in Schedule I. 
2 (ss) "Ultimate user" means a person who lawfully possesses 
3a controlled substance for his or her own use or for the use of 
4a member of his or her household or for administering to an 
5animal owned by him or her or by a member of his or her 
6household. 
7(Source: P.A. 101-666, eff. 1-1-22; 102-389, eff. 1-1-22; 
8102-538, eff. 8-20-21; 102-813, eff. 5-13-22.)

9 (720 ILCS 570/303.05)
10 Sec. 303.05. Mid-level practitioner registration. 
11 (a) The Department of Financial and Professional 
12Regulation shall register licensed physician assistants, 
13licensed advanced practice registered nurses, and prescribing 
14psychologists licensed under Section 4.2 of the Clinical 
15Psychologist Licensing Act to prescribe and dispense 
16controlled substances under Section 303 and euthanasia 
17agencies to purchase, store, or administer animal euthanasia 
18drugs under the following circumstances: 
19  (1) with respect to physician assistants, 
20   (A) the physician assistant has been delegated 
21 written authority to prescribe any Schedule III 
22 through V controlled substances by a physician 
23 licensed to practice medicine in all its branches in 
24 accordance with Section 7.5 of the Physician Assistant 
25 Practice Act of 1987; and the physician assistant has 
 
 
SB3114- 77 -LRB103 39234 SPS 69386 b


1 completed the appropriate application forms and has 
2 paid the required fees as set by rule; or 
3   (B) the physician assistant has been delegated 
4 authority by a collaborating physician licensed to 
5 practice medicine in all its branches to prescribe or 
6 dispense Schedule II controlled substances through a 
7 written delegation of authority and under the 
8 following conditions:
9    (i) Specific Schedule II controlled substances 
10 by oral dosage or topical or transdermal 
11 application may be delegated, provided that the 
12 delegated Schedule II controlled substances are 
13 routinely prescribed by the collaborating 
14 physician. This delegation must identify the 
15 specific Schedule II controlled substances by 
16 either brand name or generic name. Schedule II 
17 controlled substances to be delivered by injection 
18 or other route of administration may not be 
19 delegated;
20    (ii) any delegation must be of controlled 
21 substances prescribed by the collaborating 
22 physician;
23    (iii) all prescriptions must be limited to no 
24 more than a 30-day supply, with any continuation 
25 authorized only after prior approval of the 
26 collaborating physician;
 
 
SB3114- 78 -LRB103 39234 SPS 69386 b


1    (iv) the physician assistant must discuss the 
2 condition of any patients for whom a controlled 
3 substance is prescribed monthly with the 
4 delegating physician;
5   (A) (v) the physician assistant must have 
6 completed the appropriate application forms and paid 
7 the required fees as set by rule;
8   (B) (vi) the physician assistant must provide 
9 evidence of satisfactory completion of 45 contact 
10 hours in pharmacology from any physician assistant 
11 program accredited by the Accreditation Review 
12 Commission on Education for the Physician Assistant 
13 (ARC-PA), or its predecessor agency, for any new 
14 license issued with Schedule II authority after the 
15 effective date of this amendatory Act of the 97th 
16 General Assembly; and
17   (C) (vii) the physician assistant must annually 
18 complete at least 5 hours of continuing education in 
19 pharmacology; 
20  (2) with respect to advanced practice registered 
21 nurses who do not meet the requirements of Section 65-43 
22 of the Nurse Practice Act,
23   (A) the advanced practice registered nurse has 
24 been delegated authority to prescribe any Schedule III 
25 through V controlled substances by a collaborating 
26 physician licensed to practice medicine in all its 
 
 
SB3114- 79 -LRB103 39234 SPS 69386 b


1 branches or a collaborating podiatric physician in 
2 accordance with Section 65-40 of the Nurse Practice 
3 Act. The advanced practice registered nurse has 
4 completed the appropriate application forms and has 
5 paid the required fees as set by rule; or
6   (B) the advanced practice registered nurse has 
7 been delegated authority by a collaborating physician 
8 licensed to practice medicine in all its branches to 
9 prescribe or dispense Schedule II controlled 
10 substances through a written delegation of authority 
11 and under the following conditions:
12    (i) specific Schedule II controlled substances 
13 by oral dosage or topical or transdermal 
14 application may be delegated, provided that the 
15 delegated Schedule II controlled substances are 
16 routinely prescribed by the collaborating 
17 physician. This delegation must identify the 
18 specific Schedule II controlled substances by 
19 either brand name or generic name. Schedule II 
20 controlled substances to be delivered by injection 
21 or other route of administration may not be 
22 delegated;
23    (ii) any delegation must be of controlled 
24 substances prescribed by the collaborating 
25 physician;
26    (iii) all prescriptions must be limited to no 
 
 
SB3114- 80 -LRB103 39234 SPS 69386 b


1 more than a 30-day supply, with any continuation 
2 authorized only after prior approval of the 
3 collaborating physician;
4    (iv) the advanced practice registered nurse 
5 must discuss the condition of any patients for 
6 whom a controlled substance is prescribed monthly 
7 with the delegating physician or in the course of 
8 review as required by Section 65-40 of the Nurse 
9 Practice Act;
10    (v) the advanced practice registered nurse 
11 must have completed the appropriate application 
12 forms and paid the required fees as set by rule; 
13    (vi) the advanced practice registered nurse 
14 must provide evidence of satisfactory completion 
15 of at least 45 graduate contact hours in 
16 pharmacology for any new license issued with 
17 Schedule II authority after the effective date of 
18 this amendatory Act of the 97th General Assembly; 
19 and
20    (vii) the advanced practice registered nurse 
21 must annually complete 5 hours of continuing 
22 education in pharmacology; 
23  (2.5) with respect to advanced practice registered 
24 nurses certified as nurse practitioners, nurse midwives, 
25 or clinical nurse specialists who do not meet the 
26 requirements of Section 65-43 of the Nurse Practice Act 
 
 
SB3114- 81 -LRB103 39234 SPS 69386 b


1 practicing in a hospital affiliate,
2   (A) the advanced practice registered nurse 
3 certified as a nurse practitioner, nurse midwife, or 
4 clinical nurse specialist has been privileged to 
5 prescribe any Schedule II through V controlled 
6 substances by the hospital affiliate upon the 
7 recommendation of the appropriate physician committee 
8 of the hospital affiliate in accordance with Section 
9 65-45 of the Nurse Practice Act, has completed the 
10 appropriate application forms, and has paid the 
11 required fees as set by rule; and
12   (B) an advanced practice registered nurse 
13 certified as a nurse practitioner, nurse midwife, or 
14 clinical nurse specialist has been privileged to 
15 prescribe any Schedule II controlled substances by the 
16 hospital affiliate upon the recommendation of the 
17 appropriate physician committee of the hospital 
18 affiliate, then the following conditions must be met:
19    (i) specific Schedule II controlled substances 
20 by oral dosage or topical or transdermal 
21 application may be designated, provided that the 
22 designated Schedule II controlled substances are 
23 routinely prescribed by advanced practice 
24 registered nurses in their area of certification; 
25 the privileging documents must identify the 
26 specific Schedule II controlled substances by 
 
 
SB3114- 82 -LRB103 39234 SPS 69386 b


1 either brand name or generic name; privileges to 
2 prescribe or dispense Schedule II controlled 
3 substances to be delivered by injection or other 
4 route of administration may not be granted;
5    (ii) any privileges must be controlled 
6 substances limited to the practice of the advanced 
7 practice registered nurse;
8    (iii) any prescription must be limited to no 
9 more than a 30-day supply;
10    (iv) the advanced practice registered nurse 
11 must discuss the condition of any patients for 
12 whom a controlled substance is prescribed monthly 
13 with the appropriate physician committee of the 
14 hospital affiliate or its physician designee; and
15    (v) the advanced practice registered nurse 
16 must meet the education requirements of this 
17 Section; 
18  (3) with respect to animal euthanasia agencies, the 
19 euthanasia agency has obtained a license from the 
20 Department of Financial and Professional Regulation and 
21 obtained a registration number from the Department; or 
22  (4) with respect to prescribing psychologists, the 
23 prescribing psychologist has been delegated authority to 
24 prescribe any nonnarcotic Schedule III through V 
25 controlled substances by a collaborating physician 
26 licensed to practice medicine in all its branches in 
 
 
SB3114- 83 -LRB103 39234 SPS 69386 b


1 accordance with Section 4.3 of the Clinical Psychologist 
2 Licensing Act, and the prescribing psychologist has 
3 completed the appropriate application forms and has paid 
4 the required fees as set by rule.
5 (b) The mid-level practitioner shall only be licensed to 
6prescribe those schedules of controlled substances for which a 
7licensed physician has delegated prescriptive authority, 
8except that an animal euthanasia agency does not have any 
9prescriptive authority and a physician assistant shall have 
10prescriptive authority in accordance with the Physician 
11Assistant Practice Act of 1987 without delegation by a 
12physician. An A physician assistant and an advanced practice 
13registered nurse is are prohibited from prescribing 
14medications and controlled substances not set forth in the 
15required written delegation of authority or as authorized by 
16their practice Act. 
17 (c) Upon completion of all registration requirements, 
18physician assistants, advanced practice registered nurses, and 
19animal euthanasia agencies may be issued a mid-level 
20practitioner controlled substances license for Illinois. 
21 (d) A collaborating physician may, but is not required to, 
22delegate prescriptive authority to an advanced practice 
23registered nurse as part of a written collaborative agreement, 
24and the delegation of prescriptive authority shall conform to 
25the requirements of Section 65-40 of the Nurse Practice Act. 
26 (e) (Blank). A collaborating physician may, but is not 
 
 
SB3114- 84 -LRB103 39234 SPS 69386 b


1required to, delegate prescriptive authority to a physician 
2assistant as part of a written collaborative agreement, and 
3the delegation of prescriptive authority shall conform to the 
4requirements of Section 7.5 of the Physician Assistant 
5Practice Act of 1987. 
6 (f) Nothing in this Section shall be construed to prohibit 
7generic substitution. 
8(Source: P.A. 99-173, eff. 7-29-15; 100-453, eff. 8-25-17; 
9100-513, eff. 1-1-18; 100-863, eff. 8-14-18.)